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ABSTRACT: This work discloses a continuous flow carbonylation reaction using iron pentacarbonyl as source of CO. The described 
transformation using this surrogate was designed for use in commonly accessible flow equipment. Optimized conditions were applied 
to a scalable synthesis of the natural compound isolated from perianal glandular pheromone secretion of the African civet cat. In 
addition, a flow Pd-catalyzed carbonylation of aryl halides was successfully reported. 
INTRODUCTION		
Domino reaction processes in organic chemistry have become 
popular strategies in synthesis laboratories. The growing inter-
est in the preparation of structurally complex and biologically 
active compounds has led to an expanding effort in the devel-
opment and use of these approaches.1 Since its discovery, the 
domino palladium catalyzed carbonylative process cyclization 
has been proven as a robust and stereoselective transformation 
for the synthesis of various bicyclic lactones.2 Moreover, its 
chemical tolerance to many functional groups has been demon-
strated in various complex natural product syntheses (Scheme 
1).3 Despite the benefits of this domino transformation, there are 
certain drawbacks that inhibit its common application. One of 
the main objections being the use of toxic carbon monoxide gas, 
which is not detectable by human senses. While many modifi-
cations of the reaction conditions for this cyclization have ap-
peared over the last years,4 new approaches are always benefi-
cial, especially one using surrogates for CO gas. For compari-
son, several methods have been developed to carry out normal 
carbonylation reactions of aryl halides5 without the direct use of 
gaseous CO.6 For example, using metal carbonyls7 also or sev-
eral other CO surrogates8. Some of these methods have been 
also transferred to flow reactors.  
Scheme 1. Pd(II)-Catalyzed Carbonylative Cyclization 
 
Indeed continuous-flow methodology has become an important 
concept of contemporary chemistry for a more sustainable re-
action processing. It also facilitates the development of syn-
thetic routes requiring the safe handling of toxic agents and 
minimizing excess waste.9 Recent attention has focused on car-
bonylation reactions of aryl/alkene halides utilizing the benefits 
arising from the use of flow techniques. To date, several types 
of the continuous flow for Pd-catalyzed carbonylation have 
been reported (Figure 1).  
Generally, there are two main methods for the introduction of 
carbon monoxide into the reaction stream depending on which 
type of flow equipment is used. In 2011, we have developed the 
flow-approach for carbonylation of aryl and alkenyl iodides em-
ploying a tube-in-tube reactor with porous gas-permeable Tef-
lon AF-2400 membrane (Figure 1, I.a).10 More commonly used 
methods for precise feeding of CO into a reaction stream em-
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Figure 1. Carbonylations in Microflow Systems 
In both cases, the carbon monoxide gas is supplied from a pres-
surized cylinder. In addition, there are a few continuous-flow 
transformations utilizing CO surrogates. Hydrolysis of oxalyl 
chloride using an aqueous NaOH solution leads to in situ gen-
eration of carbon monoxide, which can then be passed through 
tube-in-tube reactor to enrich a reaction stream.12 Similar spe-
cialized reactors equipped with a CO gas permeable PTFE inner 
tube have also been successfully tested in Pd-catalyzed car-
bonylation using formic acid as an alternative CO source (Fig-
ure 1, II.a).13 Alcázar, De Borggraeve et al.14 also described con-
tinuous-flow transformation using 2,4,6-trichlorophenyl for-
mate as a CO surrogate method (Figure 1, II.b). The limitation 
of this CO surrogate is the formation of the corresponding tri-
chlorophenol esters, which requires an additional processing 
step for modification. 
RESULTS	AND	DISCUSSION	
In the course of a program directed towards CO gas-free car-
bonylation,15 we have developed a new protocol for Pd-cata-
lyzed carbonylation reactions based on the use of iron pentacar-
bonyl.15c-d However, this transformation has its limitations in 
upscaling. The instant release of gaseous CO after the addition 
of Fe(CO)5 to reaction mixture causes over-pressure in the re-
action flask. In situ generation of carbonyl species from 
Fe(CO)5 directly in the reaction mixture offers excellent oppor-
tunities for carrying out this reaction in a continuous mode. 
Here we report a flow update of homogenous Pd-catalyzed car-
bonylation reaction using iron pentacarbonyl as a CO surrogate. 
Firstly, we investigated the conditions used for common batch 
Pd-catalyzed cyclocarbonylation of (amino)alkenols. (Scheme 
2).  
Scheme 2. Batch Pd(II)-Catalyzed Cyclocarbonylation of 
pent-4-en-1,2,3-triol 1 
 
Usually, this batch transformation of unsaturated triol 1 under 
optimized reaction conditions employs 0.25 equiv of liquid 
Fe(CO)5 which corresponds to 1.25 equiv of CO. However, the 
reaction cycle necessitates the use of 4 equiv of Cu(OAc)2 and 
4 equiv of LiCl as a reoxidation system for PdCl2(CH3CN)2 cat-
alyst. Nevertheless, the reaction mixture results in a hetero-
genous mixture in acetic acid. Full conversion of substrate 
within 15 minutes is indicated by a color change of the reaction 
mixture from green to pale brown.15d Direct use of these condi-
tions to flow system was not possible due to the insolubility of 
reagents. Adjustment of the reaction components was, however, 
necessary. We began the optimization of flow reaction with Pd-
catalyzed oxycarbonylation of pent-4-en-1,2,3-triol 1. Triol 1 
was selected as a model substrate for the initial study due to its 
moderate reactivity compared to other previously used unsatu-
rated alcohols. Firstly, the reoxidation system had to be altered 
to form a soluble complex in acetic acid. Thus, changing the 
ratio of Cu(II) and Li(I) salts from 1:1 to 1:2 resulted in the for-
mation of 0.25 M green and homogenous solution at room tem-
perature in acetic acid. We could now focus on further optimi-
zation of flow reaction conditions (Table 1).16 



















































1c 4 0.3/0.4 0.08/0.55 6/10 - / - - 
2 3 0.4/0.6 0.08/0.55 6/10 - / - 33 
3 2.5 0.5/0.7 0.08/0.55 6/10 - / - 55 
4d 3 0.4/0.6 0.08/0.55 6/10 - / - 32 
5e,f 3 1.8/0.6 0.1/0.7 8/10 + / - 47 
6e,f 3 1.8/0.6 0.07/0.47 8/15 + / - 56 
7e,f 3 2.2/0.6 0.11/0.75 26/30 + / - 58 
8g 3 2.2/0.6 0.22/1.5 26/15 + / + 56 
9g 3.5 1.9/0.5 0.22/1.5 26/15 + / + 59 
10g,h 3.5 1.9/0.5 0.22/1.5 26/15 + / + 63 
aX equiv of reoxidation system corresponds to X equiv of CuCl2 
and 2X equiv of LiOAc (0.25 M solution of CuCl2 in AcOH). bCon-
centration of substrate in AcOH. cProblems with the isolation of 
product due to the large amount of salts. dReaction performed at 40 
oC. eFinal BPR was excluded. fSegmented flow was observed. g 
BPR (15 psi) at the end of flow system was used. h0.3 equiv of 
Fe(CO)5 was used. 
For these experiments a two reaction stream reactor set-up was 
devised. The reagents were loaded into the injection coils and 
pumped through a T-piece directly to 1/8-inch HPLC-tube re-
actor using Knauer Azura HPLC pumps. In some cases, mixer17 
and filtration units were incorporated into the flow system. Op-
timization reactions were conducted by altering the tempera-
ture, the size of the reactor to adjust reaction times and the 
amount of reoxidant/Fe(CO)5. The results show that the best 
 
conditions for flow reaction were using 3.5 equiv of CuCl2, 7.0 
equiv of LiOAc, 0.3 equiv of Fe(CO)5 and 0.1 equiv of Pd(II) 
catalyst (Table 1, entry 10) (0.3 equiv of Fe(CO)5 corresponds 
to 1.5 theoretical amount of CO).  
The optimal flow system involved HPLC column with frit as a 
filtration unit to avoid blocking of final back-pressure regulator 
(BPR) with solid and an in-line mixer for better agitation of two 
input streams. The reaction time was 15 min at 1.72 mL/min 
combined flow (26 mL reactor) and the product 1 was isolated 
after MPLC purification in 63% yield similarly to batch exper-
iment.  
Table 2. Continuous Flow Pd(II)-Catalyzed Carbonylation 



































65 (4a, R=Boc) 
50 (4b, R=Cbz) 












71 (10a, R=Boc) 
77 (10b, R=Cbz) 



























With this optimized flow setup, we examined the Pd-catalyzed 
carbonylation of different alkenols and aminoalkenols (Table 
2). Unsaturated alcohols as substrates were available from our 
previous study15d, 18-20 and prepared by identical preparative pro-
cedures (see Experimental section). 
By applying the optimized conditions, non-complex lactones 2, 
4, 6, 8, 10 and 20 were isolated after the MPLC purification in 
similar yields compared to batch experiments (Table 2, entries 
1-5 and 10). We also prepared the Hagen´s gland lactones 12 
and 14 in 62 and 77% yield, respectively (Table 2, entries 6 and 
7).18,19 Substrate 21 was transformed using the flow chemistry 
system into lactone 22 that had been previously used in the for-
mal synthesis of pyrenolide D (61% yield, Table 2, entry 11).3a 
To prove the versatility and effectiveness of this flow transfor-
mation, longer run experiments were investigated using sub-
strates 7 and 23. The flow system was adjusted for direct pump-
ing of the reagent solutions via Azura HPLC pumps. Also, sub-
strates and Fe(CO)5 were pumped separately to the system. A 
higher amount of LiOAc (10.5 equiv) in these experiments was 
used to prevent precipitation of the reoxidation salt in the stock 
solution. Following 193 min long experiment using substrate 7 
provided product 8 (2.66 g) in 83% yield.21 Similarly, a large 
scale synthesis of the natural compound isolated from perianal 
glandular pheromone secretion of the African civet cat. (1.52 g) 
using this system was accomplished. The product (±)-syn-24 
was isolated after 172 min long run in 53% yield (Figure 2).  
Figure 2. Large scale flow synthesis of natural compound (±)-syn-
24 
The above results suggest the protocol may be applied to Pd-
catalyzed carbonylative couplings of aryl halides. The condi-
tions for Pd-catalyzed aminocarbonylation of p-iodoanisole are 
based on our previously reported study22 and applied in flow 
carbonylation using Fe(CO)5 as a CO surrogate (Figure 3). This 
transformation after few optimization experiments readily pro-
vided expected product in 64% yield. 
 
Figure 3. Preliminary flow chemistry setup for aminocarbonyla-
tion reactions of aryl iodides. 
CONCLUSION	
In summary, we have demonstrated the compatibility of iron 
pentacarbonyl as a CO surrogate for carbonylation reactions in 
a flow reactor. We have shown the Pd-catalyzed cyclocarbonyl-
ation reactions of unsaturated alcohols and aminoalcohols using 
Fe(CO)5 in a continuous microflow system. The robust process 
proceeds in readily constructed tube-reactor providing lactones 
in good yields comparable with batch experiments. The ability 
to scale-up these reactions in flow in a contained environment, 
is an advantage in providing access to these useful lactonic 
building block precursors.  
EXPERIMENTAL	SECTION		
General information 
Commercial materials which were obtained from Sigma-
Aldrich, Acros Organics, Alfa Aesar or Fisher Scientific were 
used without further purification. Reactions were monitored 
using TLC on silica gel. Compound purification was affected 
by flash chromatography. All solvents were distilled before use. 
Hexanes refer to the fraction boiling at 60-65 oC. Flash column 
liquid chromatography (FLC) was performed on silica gel 
Kieselgel 60 (15-40 µm, 230-400 mesh) and analytical thin-
layer chromatography (TLC) was performed on aluminium 
plates pre-coated with either 0.2 mm (DC-Alufolien, Merck) or 
0.25 mm silica gel 60 F254 (ALUGRAM® SIL G/UV254, 
Macherey-Nagel). Analyzed compounds were visualized by 
UV fluorescence and by dipping the plates in an aqueous H2SO4 
solution of cerium sulphate/ammonium molybdate followed by 
charring with a heat gun. Melting points were obtained using a 
Boecius apparatus and are uncorrected. 1H and 13C NMR 
spectra were recorded on either 300 (75) MHz MercuryPlus or 
600 (151) MHz Unity Inova spectrometers from Varian. 
Chemical shifts (d) are quoted in ppm and are referenced to the 
tetramethylsilane (TMS), CDCl3 or DMSO-d6 as internal 
standard. FTIR spectra were obtained on a Nicolet 5700 
spectrometer (Thermo Electron) equipped with a Smart Orbit 
(diamond crystal ATR) accessory, using the reflectance 
technique (4000-400 cm-1). High resolution mass spectra 
(HRMS) were recorded on an OrbitrapVelos mass spectrometer 
(Thermo Scientific, Waltham, MA, USA; Bremen, Germany) 
with a heated electrospray ionization (HESI) source. The mass 
spectrometer was operated with full scan (50–2000 amu) in 
positive or negative FT mode (at a resolution of 100,000). The 
sample was dissolved in methanol and infused via syringe pump 
at a rate of 5 mL/min. The heated capillary was maintained at 
275 °C with a source heater temperature of 50 °C and the sheath, 
auxiliary and sweep gases were at 10, 5 and 0 units, 
respectively. Source voltage was set to 3.5 kV. 
General procedure for flow carbonylation reactions 
General method 1: Injection coil A (3.9 mL, PTFE tubing, 1/8” 
o.d., 1/16” i.d.) was loaded with a solution of substrate (1.90 
mmol, 1 equiv) and Fe(CO)5 (75 µL, 0.57 mmol, 0.3 equiv) in 
glacial AcOH. Injection coil B (26.8 mL, PTFE tubing, 1/8” 
o.d., 1/16” i.d.) was loaded with a solution of CuCl2 (0.89 g, 
6.64 mmol, 3.5 equiv), LiOAc (0.88 g, 13.27 mmol, 7 equiv) 
and PdCl2(CH3CN)2 (0.05 g, 0.19 mmol, 0.1 equiv) in glacial 
AcOH. These reaction mixtures were pumped using HPLC 
pumps (Knauer Azura 4.1S with 10 mL pump head) at 0.22 
mL/min and 1.5 mL/min flowrate and mixed at a T-piece. 
Mixing of both streams was performed by installed magnetic 
mixer. Subsequently, combined reaction solutions were 
directed to a reactor (25.7 mL, PTFE tubing, 1/8” o.d., 1/16” 
i.d) heated in 60 °C water bath. The installation of backpressure 
regulators (2 × 10 psi) in front of the T-piece was used to ensure 
unidirectional flow through the heating coil (reactor). On 
exiting the heating coils, the product flow stream was directed 
through a glass Omnifit column (15 mm i.d. × 100 mm length) 
with filter to remove any solids. A backpressure regulator (15 
psi) was placed immediately after the glass Omnifit column to 
prevent out-gassing of the dissolved CO from the solvent 
mixture. The product stream was then collected into a round 
bottom flask. The reaction mixture was then concentrated in 
vacuo and the residue was purified by MPLC. 
General method 2: A solution of substrate (0.98 M in AcOH, 
stream A) and the solution of Fe(CO)5 (0.29 M in AcOH, stream 
B) were pumped using HPLC pumps (Knauer Azura 4.1S with 
10 mL pump head) at 0.11 mL/min flowrate and mixed together 
in T-piece. The combined streams were united with a third 
solvent stream C (solution of CuCl2 (0.25 M), LiOAc (0.74 M) 
and PdCl2(CH3CN)2 (0.007 M) in AcOH, 1.5 mL/min, pumped 
by HPLC pump Knauer Azura 4.1S with 10 mL pump head) via 
a second T-piece. Mixing of streams was performed by installed 
magnetic mixer. Subsequently, the combined reaction solutions 
were directed to a reactor (25.7 mL, PTFE tubing, 1/8” o.d., 
1/16” i.d.) heated in 60 °C water bath. The installation of 
backpressure regulators (3 × 10 psi) in front of the T-piece was 
used to ensure unidirectional flow through the heating coils 
(reactor). On exiting the heating coil (reactor), the product flow 
stream was directed through a glass Omnifit column (15 mm 
i.d. × 100 mm length) with filter to remove any solids. A 
backpressure regulator (15 psi) was placed immediately after 
the glass Omnifit column to prevent out-gassing of the 
dissolved CO from the solvent mixture. The product stream was 
then collected into a round bottom flask. The reaction mixture 
was then concentrated in vacuo and the crude product was 
purified by MPLC. 
General method 3: A solution of substrate (0.98 M in AcOH, 
stream A) and the solution of Fe(CO)5 (0.25 M in AcOH, stream 
B) were pumped using HPLC pumps (Knauer Azura 4.1S with 
10 mL pump head) at 0.32 mL/min flowrate and mixed together 
in T-piece. The combined streams were united with a third 
stream C (solution of CuCl2 (0.25 M), LiOAc (0.51M) and 
PdCl2(CH3CN)2 (0.007 M) in AcOH, 4.36 mL/min, pumped by 
HPLC pump Knauer Azura 4.1S with 10 mL pump head) via a 
second T-piece. Mixing of streams was performed by installed 
 
magnetic mixer. Subsequently, the combined reaction solutions 
were directed to a reactor (15 mL, PTFE tubing, 1/8” o.d., 1/16” 
i.d.) heated in 80 °C water sonication bath. The installation of 
backpressure regulators (3 × 45 psi) in front of the T-piece was 
used to ensure unidirectional flow through the heating coils 
(reactor). On exiting the heating coil (reactor), the product flow 
stream was directed through a glass Omnifit column (15 mm 
i.d. × 100 mm length) with filter to remove any solids. A 
backpressure regulator (45 psi) was placed immediately after 
the glass Omnifit column to prevent out-gassing of the 
dissolved CO from the solvent mixture. The product stream was 
then collected into a round bottom flask. The reaction mixture 
was then concentrated in vacuo and the crude product was 
purified by MPLC. 
(1R,5R,8R)-8-Hydroxy-2,6-dioxabicyclo[3.3.0]octan-3-one 
(2). The title compound was prepared according to general 
method 1 from triol 1 (224 mg, 1.90 mmol). The purification of 
crude product by MPLC (hexanes/EtOAc: 100/0 to 40/60 then 
isocratic hexanes/EtOAc: 40/60) provided desired lactone 2 
(172 mg, 63%, white solid). All physical and spectral data were 
in good agreement with the literature.23 Rf = 0.20 
(hexanes/EtOAc, 2:3); mp 76.5-77.0 °C, lit. 24 mp 77.0-79.0 °C; 
[α]D
20
 +87.8 (c 1.10, CHCl3); IR (ATR) νmax 3363, 1763, 1144, 
1041, 588 cm-1; 1H NMR (300 MHz, CD3OD) δH 4.98 (t, J = 4.9 
Hz, 1H, H-1), 4.76 (ddd, J = 6.7, 4.9, 1.5 Hz, 1H, H-5), 4.42 
(ddd, J = 6.9, 6.0, 4.9 Hz, 1H, H-8), 3.93 (dd, J = 9.0, 6.0 Hz, 
1H, H-7a), 3.67 (dd, J = 9.0, 6.9 Hz, 1H, H-7b), 2.92 (dd, J = 
18.6, 6.7 Hz, 1H, H-4a), 2.58 (dd, J = 18.6, 1.5 Hz, 1H, H-4b) 
ppm; 13C NMR{1H} (75 MHz, CD3OD) δc 178.3, 84.7, 78.4, 
72.6, 71.9, 37.4 ppm; HRMS (ESI): m/z [M+H]+ Calcd. 
for:C6H9O4: 145.0501, Found: 145.0496, [M+Na]+ Calcd. for 
C6H8NaO4: 167.0320, Found: 167.0315. 
(1S,5R,8R)-8-Hydroxy-6-tert-butyloxycarbonyl-2-oxa-6-
azabicyclo[3.3.0]octan-3-one (4a). The title compound was 
prepared according to general method 1 from aminodiol 3a (412 
mg, 1.90 mmol). The purification of crude product by MPLC 
(hexanes/EtOAc: 100/0 to 50/50 then isocratic hexanes/EtOAc: 
50/50) provided desired lactone 4a (300 mg, 65%, white solid). 
All physical and spectral data were in good agreement with the 
literature.15d Rf = 0.20 (hexanes/EtOAc, 1:1); mp 128.1-128.4 
°C; [α]D
20
 -80.7 (c 0.48, CHCl3); IR (ATR) νmax 3367, 2980, 
1774, 1670, 1403 cm-1; 1H NMR (300 MHz, CDCl3, mixture of 
rotamers) δH 4.96-4.92 (m, 1H, H-1), 4.51-4.38 (m, 2H, H-5 and 
H-8), 3.90-3.80 (m, 1H, H-7a), 3.37-3.20 (m, 1H, H-7b), 2.84-
2.70 (m, 2H, H-4), 2.41 (br s, 1H, OH), 1.46 (s, 9H, C(CH3)3) 
ppm; 13C NMR{1H} (75 MHz, CDCl3, mixture of rotamers) δC 
175.7, 175.4, 153.9, 153.3, 82.5, 81.9, 80.9, 70.6, 69.9, 55.9, 
50.1, 49.9, 36.7, 36.1, 28.8 ppm; HRMS (ESI): m/z [M+H]+ 
Calcd. for:C11H18NO5: 244.1185, Found: 244.1179, [M+Na]+ 
Calcd. for C11H17NNaO5: 266.1004, Found: 266.0999, [M+K]+ 
Calcd. for C11H17KNO5: 282.0744, Found: 282.0738. 
(1S,5R,8R)-6-Benzyloxycarbonyl-8-hydroxy-2-oxa-6-
azabicyclo[3.3.0]octan-3-one (4b). The title compound was 
prepared according to general method 1 from aminodiol 3b (477 
mg, 1.90 mmol). The purification of crude product by MPLC 
(hexanes/EtOAc: 100/0 to 40/60 then isocratic hexanes/EtOAc: 
40/60) provided desired lactone 4b (263 mg, 50%, orange 
solid). All physical and spectral data were in good agreement 
with the literature.25 Rf = 0.20 (hexanes/EtOAc, 2:3); mp 107.1-
107.6 °C, lit.26 mp 108-109 °C; [α]D
20
 -66.8 (c 1.69, CHCl3); IR 
(ATR) νmax 3446, 1776, 1690, 1417, 1096 cm-1; 1H NMR (300 
MHz, CDCl3, mixture of rotamers) δH 7.40-7.30 (m, 5H, HAr), 
5.18-5.07 (m, 2H, PhCH2), 4.92 (dd, J = 5.7, 4.4 Hz, 1H, H-1), 
4.56-4.46 (m, 1H, H-5), 4.40-4.34 (m, 1H, H-8), 3.91-3.85 (m, 
1H, H-7a), 3.44-3.30 (m, 1H, H-7b), 3.08 (br s, 1H, OH), 2.93-
2.67 (m, 2H, H-4) ppm; 13C NMR{1H} (75 MHz, CDCl3, 
mixture of rotamers) δC 175.6, 175.3, 154.6, 154.1, 136.1, 
128.8, 128.7, 128.5, 128.4, 128.2, 82.4, 81.8, 70.6, 69.9, 67.8, 
67.6, 56.4, 55.9, 50.5, 50.0, 36.7, 36.0 ppm; HRMS (ESI): m/z 
[M+H]+ Calcd. for:C14H16NO5: 278.1029, Found: 278.1023, 
[M+Na]+ Calcd. for C14H15NNaO5: 300.0848, Found: 300.0844. 
(1S,5R,8R)-8-Hydroxy-6-tosyl-2-oxa-6-
azabicyclo[3.3.0]octan-3-one (4c). The title compound was 
prepared according to general method 1 from aminodiol 3c (515 
mg, 1.90 mmol). The purification of crude product by MPLC 
(hexanes/EtOAc: 100/0 to 60/40 then isocratic hexanes/EtOAc: 
60/40) provided desired lactone 4c (350 mg, 62%, white solid). 
All physical and spectral data were in good agreement with the 
literature.15d Rf = 0.20 (hexanes/EtOAc, 2:3); mp 141.9-142.4, 
lit.15d mp 140-141 °C; IR (ATR) νmax 3419, 1757, 1341, 1160, 
537 cm-1; 1H NMR (300 MHz, CDCl3) δH 7.71 (d, J = 8.1 Hz, 
2H, HAr), 7.36 (d, J = 8.1 Hz, 2H, HAr), 4.80 (dd, J = 6.5, 4.5 
Hz, 1H, H-1), 4.40 (td, J = 6.5, 4.2 Hz, 1H, H-5), 4.08 (td, J = 
6.3, 4.5 Hz, 1H, H-8), 3.58 (dd, J = 11.3, 6.3 Hz, 1H, H-7a), 3.36 
(dd, J = 11.3, 6.3 Hz, 1H, H-7b), 2.92-2.87 (m, 2H, H-4), 2.45 
(s, 3H, CH3) ppm; 13C NMR{1H} (75 MHz, CDCl3) δC 174.6, 
144.7, 134.5, 130.3, 127.4, 81.7, 70.4, 57.6, 52.1, 36.9, 21.7 
ppm; HRMS (ESI): m/z [M+H]+ Calcd. for:C13H16NO5S: 
298.0749, Found: 298.0745, [M+Na]+ Calcd. for 
C13H15NNaO5S: 320.0569, Found: 320.0564. 
rac-7,7-Dimethyl-2,6-dioxabicyclo[3.3.0]octane-3-one ((±)-
8). The title compound was prepared according to general 
method 1 from diol (±)-7 (247 mg, 1.90 mmol). The purification 
of crude product by MPLC (hexanes/EtOAc: 100/0 to 60/40 
then isocratic hexanes/EtOAc: 60/40) provided desired lactone 
(±)-8 (245 mg, 83%, colorless oil). According to general 
method 2 in 193 min. long run 2.656 g (83%) of (±)-8 was 
obtained. According to general method 3 in 180 min. long run 
7.014 g (80%) of (±)-8 was obtained.All physical and spectral 
data were in good agreement with the literature.15d Rf = 0.20 
(hexanes/EtOAc, 3:2); IR (ATR) νmax 2973, 1170, 1154, 1065, 
904 cm-1; 1H NMR (300 MHz, CDCl3) δH 5.05 (ddd, J = 5.9, 
4.7, 2.1 Hz, 1H, H-5), 4.73 (td, J = 4.7, 1.7 Hz, 1H, H-1), 2.75 
(dd, J = 18.3, 4.7 Hz, 1H, H-8a), 2.67 (dd, J = 18.3, 1.7 Hz, 1H, 
H-8b), 2.20 (dd, J = 14.5, 2.1 Hz, 1H, H-4a), 2.13 (dd, J = 14.5, 
5.9 Hz, 1H, H-4b), 1.34 (s, 3H, CH3), 1.26 (s, 3H, CH3) ppm; 
13C NMR{1H} (75 MHz, CDCl3) δC 175.9, 86.1, 83.2, 77.5, 
45.0, 37.3, 29.3, 28.7 ppm; HRMS (ESI): m/z [M+H]+ Calcd. 
for:C8H13O3: 157.08647, Found: 157.08598, [M+Na]+ Calcd. 
for C8H12NaO3: 179.06841, Found: 179.06795. 
rac-2,6-Dioxabicyclo[3.3.0]octane-3-one ((±)-6). The title 
compound was prepared according to general method 1 from 
diol (±)5 (194 mg, 1.90 mmol). The purification of crude 
product by MPLC (hexanes/EtOAc: 100/0 to 50/50 then 
isocratic hexanes/EtOAc: 50/50) provided desired lactone (±)-
6 (199 mg, 82%, colorless oil). All physical and spectral data 
were in good agreement with the literature.27 Rf = 0.20 
(hexanes/EtOAc, 1:1); IR (ATR) νmax 1766, 1181, 1066, 1026, 
828 cm-1; 1H NMR (300 MHz, CDCl3) δH 5.15-5.07 (m, 1H, H-
1), 4.69 (ddd, J = 5.8, 4.5, 0.7 Hz, 1H, H-5), 4.01-3.88 (m, 2H, 
H-7), 2.77 (dd, J = 18.7, 5.8 Hz, 1H, H-4a), 2.66 (dd, J = 18.7, 
0.7 Hz, 1H, H-4b), 2.37-2.26 (m, 1H, H-8a), 2.27-2.07 (m, 1H, 
H-8b) ppm; 13C NMR{1H} (75 MHz, CDCl3) δC 175.9, 84.4, 
78.2, 67.1, 36.4, 33.2 ppm; HRMS (ESI): m/z [M+H]+ Calcd. 
 
for:C6H9O3: 129.0552, Found: 129.0546, [M+Na]+ Calcd. for 
C6H8NaO3: 151.0371, Found: 151.0366. 
rac-6-(tert-Butyloxycarbonyl)-2-oxa-6-
azabicyclo[3.3.0]octan-3-one ((±)-10a). The title compound 
was prepared according to general method 1 from amino 
alcohol (±)-9a (382 mg, 1.90 mmol). The purification of crude 
product by MPLC (hexanes/EtOAc: 100/0 to 60/40 then 
isocratic hexanes/EtOAc: 60/40) provided desired lactone (±)-
10a (306 mg, 71%, white solid). All physical and spectral data 
were in good agreement with the literature.28 Rf = 0.20 
(hexanes/EtOAc, 3:2); mp 108.3-108.7, lit.28 mp 109-110 °C; 
IR (ATR) νmax 1768, 1681, 1409, 1163, 770 cm-1; 1H NMR (300 
MHz, CDCl3, mixture of rotamers) δH 5.05 (br s, 1H, H-1), 4.49-
4.39 (m, 1H, H-5), 3.82-3.65 (m, 1H, H-7a), 3.35 (td, J = 11.1, 
6.1 Hz, 1H, H-7b), 2.90-2.67 (m, 2H, H-4), 2.29 (dd, J = 14.2, 
6.1 Hz, 1H, H-8a), 2.09-1.96 (m, 1H, H-8b) 1.46 (s, 9H, 
C(CH3)3) ppm; 13C NMR{1H} (75 MHz, CDCl3, mixture of 
rotamers) δC 176.0, 175.6, 153.9, 153.3, 84.3, 83.3, 80.7, 58.0, 
44.4, 44.1, 36.8, 36.0, 30.8, 30.3, 28.6. ppm; HRMS (ESI): m/z 
[M+H]+ Calcd. for:C11H18NO4: 228.1236, Found: 228.1230, 
[M+Na]+ Calcd. for C11H17NNaO4: 250.1055, Found: 250.1050, 
[M+K]+ Calcd. for C11H17KNO4: 266.0795, Found: 266.0789. 
rac-6-Benzyloxycarbonyl-2-oxa-6-azabicyclo[3.3.0]octan-
3-one ((±)-10b)The title compound was prepared according to 
general method 1 from amino alcohol (±)-9b (446 mg, 1.90 
mmol). The purification of crude product by MPLC 
(hexanes/EtOAc: 100/0 to 50/50 then isocratic hexanes/EtOAc: 
50/50) provided desired lactone (±)-10b (381 mg, 77%, pale 
yellow solid). All physical and spectral data were in good 
agreement with the literature.29 Rf = 0.20 (hexanes/EtOAc, 1:1); 
mp 99.0-99.5, lit.29 mp 100-101 °C; IR (ATR) νmax 1762, 1697, 
1419, 1111, 734 cm-1; 1H NMR (300 MHz, CDCl3, mixture of 
rotamers) δH 7.40-7.30 (m, 5H, HAr), 5.19-5.08 (m, 3H, H-1, 
PhCH2), 4.54-4.45 (m, 1H, H-5), 3.91-3.76 (m, 1H, H-7a), 3.43 
(td, J = 11.1, 6.2 Hz, 1H, H-7b), 2.94-2.69 (m, 2H, H-4), 2.32 
(dd, J = 14.1, 6.2 Hz, 1H, H-8a), 2.11-1.98 (m, 1H, H-8b) ppm; 
13C NMR{1H} (75 MHz, CDCl3, mixture of rotamers) δC 175.6, 
175.2, 154.4, 154.0, 136.3, 128.8, 128.7, 128.5, 128.3, 128.3, 
128.2, 84.1, 83.1, 67.6, 67.4, 58.5, 57.9, 44.7, 44.3, 36.7, 35.8, 
30.8, 30.4. ppm; HRMS (ESI): m/z [M+H]+ Calcd. 
for:C14H16NO4: 262.1079, Found: 262.1074, [M+Na]+ Calcd. 
for C14H15NNaO4: 284.0899, Found: 284.0893, [M+K]+ Calcd. 
for C14H15KNO4: 300.0638, Found: 300.0633. 
rac-6-Tosyl-2-oxa-6-azabicyclo[3.3.0]octan-3-one ((±)-
10c). The title compound was prepared according to general 
method 1 from amino alcohol (±)-9c (485 mg, 1.90 mmol). The 
purification of crude product by MPLC (hexanes/EtOAc: 100/0 
to 50/50 then isocratic hexanes/EtOAc: 50/50) provided desired 
lactone (±)-10c (433 mg, 81%, white solid). All physical and 
spectral data were in good agreement with the literature.30 Rf = 
0.20 (hexanes/EtOAc, 1:1); mp 131.9-132.5, lit.30 mp 133-134 
°C; IR (ATR) νmax 1773, 1335, 1156, 973, 573 cm-1; 1H NMR 
(300 MHz, CDCl3) δH 7.75-7.68 (m, 2H, HAr), 7.35 (dd, J = 8.6, 
0.7 Hz, 2H, HAr), 4.96 (td, J = 5.4, 1.4 Hz, 1H, H-1), 4.37 (ddd, 
J = 6.6, 5.4, 1.3 Hz, 1H, H-5), 3.58 (ddd, J = 11.3, 8.6, 2.7 Hz, 
1H, H-7a), 3.53-3.42 (m, 1H, H-7b), 2.96 (dd, J = 18.7, 1.3 Hz, 
1H, H-4a), 2.84 (dd, J = 18.7, 6.6 Hz, 1H, H-4b), 2.45 (s, 3H, 
CH3), 2.25-2.13 (m, 1H, H-8a), 1.83-1.68 (m, 1H, H-8b) ppm; 
13C NMR{1H} (75 MHz, CDCl3) δC 174.9, 144.4, 134.9, 130.0, 
127.3, 83.5, 60.1, 47.0, 36.8, 31.3, 21.7 ppm; HRMS (ESI): m/z 
[M+H]+ Calcd. for:C13H16NO4S: 282.0800, Found: 282.0795, 
[M+Na]+ Calcd. for C13H15NNaO4S: 304.0620, Found: 
304.0614, [M+K]+ Calcd. for C13H15KNO4S: 320.0359, Found: 
320.0353. 
D-ido/D-galacto-7-methyl-8-hydroxy-2,6-
dioxabicyclo[3.3.0]octan-3-one (22). The title compounds were 
prepared according to general method 1 from mixture of 
(2R,3S,4S)-hex-5-ene-2,3,4-triol and (2R,3S,4R)-hex-5-ene-
2,3,4-triol (ratio 40:60) (251 mg, 1.90 mmol). The purification 
of crude product by MPLC (hexanes/EtOAc: 100/0 to 40/60 
then isocratic hexanes/EtOAc: 40/60) provided desired lactones 
D-ido/D-galacto (22) as inseparable mixture (183 mg, 61%, 
ratio: 60:40 from 1H NMR, white solid). All physical and 
spectral data of D-ido 22 were in good agreement with the 
literature.31 Rf = 0.20 (hexanes/EtOAc, 2:3); mp 136.8-137.3, 
lit.31 mp 138-140 °C; IR (ATR) νmax 3344, 1767, 1138, 1040, 
822 cm-1; D-ido (22): 1H NMR (300 MHz, CDCl3) δH 4.98 (dd, 
J = 10.6, 4.9 Hz, 1H, H-1), 4.95-4.89 (m, 1H, H-5), 4.25-4.22 
(m, 1H, H-8), 4.14 (qd, J = 6.3, 2.8 Hz, 1H, H-7), 2.81-2.58 (m, 
2H, H-4), 2.01 (s, 1H, OH), 1.30 (t, J = 6.3 Hz, 3H, CH3) ppm; 
13C NMR{1H} (75 MHz, CDCl3) δC 175.8, 88.1, 76.3, 76.0, 
75.5, 36.0, 13.1 ppm; D-galacto (22): 1H NMR (300 MHz, 
CDCl3) δH 4.95-4.89 (m, 1H, H-1), 4.59 (td, J = 6.1, 3.1 Hz, 1H, 
H-5), 4.28-4.25 (m, 1H, H-8), 3.95 (qd, J = 6.3, 4.2 Hz, 1H, H-
7), 2.81-2.58 (m, 2H, H-4), 2.01 (s, 1H, OH), 1.30 (t, J = 6.3 
Hz, 3H, CH3) ppm; 13C NMR{1H} (75 MHz, CDCl3) δC 175.4, 
83.5, 79.0, 75.8, 72.1, 36.2, 14.0 ppm; HRMS (ESI): m/z 
[M+H]+ Calcd. for:C7H11O4: 159.0657, Found: 159.0653, 
[M+Na]+ Calcd. for C7H10NaO4: 181.0477, Found: 181.0472.  
rac-(1R,5R,7S)-7-Phenyl-2,6-dioxabicyclo[3.3.0]octane-3-
one ((±)-exo-20) and rac-(1R,5R,7R)-7-Phenyl-2,6-
dioxabicyclo[3.3.0]octane-3-one ((±)-endo-20). The title 
compounds were prepared according to general method 1 from 
diol (±)-19 (338 mg, 1.90 mmol). The purification of crude 
product by MPLC (hexanes/EtOAc: 100/0 to 75/25 then 
isocratic hexanes/EtOAc: 75/25) provided desired lactones (±)-
exo-20 (178 mg, 46%, orange oil) and (±)-endo-20 (58 mg, 
15%, orange oil). All physical and spectral data of (±)-exo-20 
were in good agreement with the literature.32 (±)-exo-20: Rf = 
0.20 (hexanes/EtOAc, 7:3); IR (ATR) νmax 1774, 1171, 1059, 
944, 754 cm-1; 1H NMR (300 MHz, CDCl3) δH 7.41-7.27 (m, 
5H, HAr), 5.24 (t, J = 4.8 Hz, 1H, H-1), 5.13 (dd, J = 10.6, 4.8 
Hz, 1H, H-7), 5.05 (ddd, J = 5.8, 4.8, 1.6 Hz, 1H, H-5), 2.91-
2.79 (m, 2H, H-4), 2.71 (dd, J = 14.2. 4.8 Hz, 1H, H-8a), 2.10-
1.98 (m, 1H, H-8b) ppm; 13C NMR{1H} (75 MHz, CDCl3) δC 
176.0, 140.0, 128.8, 128.2, 125.9, 85.0, 79.8, 78.4, 41.7, 36.8 
ppm; HRMS (ESI): m/z [M+H]+ Calcd. for:C12H13O3: 205.0865, 
Found: 205.0858, [M+Na]+ Calcd. for C12H12NaO3: 227.0684, 
Found: 227.0678, [M+K]+ Calcd. for C12H12KO3: 243.0424, 
Found: 243.0417; (±)-endo-20: Rf = 0.20 (hexanes/EtOAc, 7:3); 
IR (ATR) νmax 1775, 1194, 1029, 754, 581 cm-1; 1H NMR (300 
MHz, CDCl3) δH 7.41-7.27 (m, 5H, HAr), 5.14 (ddd, J = 7.0, 4.6, 
2.4 Hz, 1H, H-1), 4.97 (dd, J = 8.3, 7.6 Hz, 1H, H-7), 4.69 (td, 
J = 4.6, 1.6 Hz, 1H, H-5), 2.93-2.82 (m, 2H, H-4), 2.82-2.74 (m, 
1H, H-8a), 2.26 (ddd, J = 14.5, 8.3, 2.4 Hz, 1H, H-8b) ppm; 13C 
NMR{1H} (75 MHz, CDCl3) δC 175.4, 140.1, 128.8, 128.3, 
126.2, 84.7, 81.8, 79.0, 41.1, 36.3 ppm; HRMS (ESI): m/z 
[M+H]+ Calcd. for:C12H13O3: 205.0865, Found: 205.0859, 
[M+Na]+ Calcd. for C12H12NaO3: 227.0684, Found: 227.0679, 
[M+K]+ Calcd. for C12H12KO3: 243.0424, Found: 243.0419. 
rac-(1R,5R,7R)-7-nHexyl-2,6-dioxabicyclo[3.3.0]octane-3-
one ((±)-12). The title compound was prepared according to 
general method 1 from diol (±)-11 (354 mg, 1.90 mmol). The 
purification of crude product by MPLC (hexanes/EtOAc: 100/0 
to 80/20 then isocratic hexanes/EtOAc: 80/20) provided desired 
 
lactone (±)-12 (250 mg, 62%, pale yellow oil). All physical and 
spectral data were in good agreement with the literature.18 Rf= 
0.20 (hexanes/EtOAc, 4:1); IR (ATR) νmax 2927, 1777, 1170, 
1059, 831 cm-1; 1H NMR (300 MHz, CDCl3) δH 5.11 (t, J = 4.8 
Hz, 1H, H-1), 4.84-4.78 (m, 1H, H-5), 4.12-4.01 (m, 1H, H-7), 
2.76 (dd, J = 18.8, 6.3 Hz, 1H, H-4a), 2.64 (d, J = 18.8 Hz, 1H, 
H-4b), 2.37 (ddd, J = 13.9, 4.8, 0.6 Hz, 1H, H-8a), 1.66 (ddd, J 
= 13.9, 10.4, 5.0 Hz, 1H, H-8b), 1.60-1.38 (m, 2 H, 
CH2(CH2)4CH3), 1.38-1.19 (m, 8 H, CH2(CH2)4CH3), 0.88 (t, J 
= 7.0 Hz, 3H, CH3) ppm; 13C NMR {1H} (75 MHz, CDCl3) δC 
176.2, 85.1, 78.4, 77.5, 39.0, 36.8, 34.8, 31.9, 29.4, 26.1, 22.7, 
14.2 ppm; HRMS (ESI): m/z [M+H]+ Calcd. for:C12H21O3: 
213.1491, Found: 213.1485, [M+Na]+ Calcd. for C12H20NaO3: 
235.1310, Found: 235.1305. 
rac-(1R,5R,7S)-7-nHexyl-2,6-dioxabicyclo[3.3.0]octane-3-
one ((±)-16). The title compound was prepared according to 
general method 1 from diol (±)-15 (354 mg, 1.90 mmol). The 
purification of crude product by MPLC (hexanes/EtOAc: 100/0 
to 80/20 then isocratic hexanes/EtOAc: 80/20) provided desired 
lactone (±)-16 (157 mg, 39%, pale yellow oil). All physical and 
spectral data were in good agreement with the literature.18 Rf = 
0.20 (hexanes/EtOAc, 4:1); IR (ATR) νmax 2928, 1775, 1152, 
1066, 893 cm-1; 1H NMR (300 MHz, CDCl3) δH 5.00 (ddd, J = 
6.9, 4.5, 2.3 Hz, 1H, H-1), 4.53-4.43 (m, 1H, H-5), 3.97-3.86 
(m, 1H, H-7), 2.73-2.66 (m, 2H, H-4), 2.41 (dt, J = 14.2, 6.9 Hz, 
1H, H-8a), 1.86 (ddd, J = 14.2, 7.9, 2.3 Hz, 1H, H-8b), 1.73-1.43 
(m, 2H, CH2(CH2)4CH3), 1.43-1.12 (m, 8H, CH2(CH2)4CH3), 
0.86 (t, J = 7.0 Hz, 3H, CH3) ppm; 13C NMR (75 MHz, CDCl3) 
δC 175.6, 84.8, 80.5, 78.3, 38.4, 36.5, 35.6, 31.8, 29.3, 26.1, 
22.7, 14.2 ppm; HRMS (ESI): m/z [M+H]+ Calcd. for:C12H21O3: 
213.1491, Found: 213.1485, [M+Na]+ Calcd. for C12H20NaO3: 
235.1310, Found: 235.1304, [M+K]+ Calcd. for C12H20KO3: 
251.1050, Found: 251.1043. 
rac-(1R,5R,7R)-7-nButyl-2,6-dioxabicyclo[3.3.0]octane-3-
one ((±)-14). The title compound was prepared according to 
general method 1 from diol (±)-13 (300 mg, 1.90 mmol). The 
purification of crude product by MPLC (hexanes/EtOAc: 100/0 
to 75/25 then isocratic hexanes/EtOAc: 75/25) provided desired 
lactone (±)-14 (269 mg, 77%, pale yellow oil). All physical and 
spectral data were in good agreement with the literature.18 Rf = 
0.20 (hexanes/EtOAc, 4:1); IR (ATR) νmax 2931, 1774, 1175, 
1059, 832 cm-1; 1H NMR (300 MHz, CDCl3) δH 5.11 (t, J = 4.9 
Hz, 1H, H-1), 4.84-4.77 (m, 1H, H-5), 4.12-4.00 (m, 1H, H-7), 
2.76 (dd, J = 18.8, 6.4 Hz, 1H, H-4a), 2.63 (d, J = 18.8 Hz, 1H, 
H-4b), 2.37 (dd, J = 13.9, 4.7 Hz, 1H, H-8a), 1.66 (dd, J = 13.9, 
10.4, 4.9 Hz, 1H, H-4b), 1.60-1.43 (m, 2H, CH2(CH2)2CH3), 
1.43-1.17 (m, 4H, CH2(CH2)2CH3), 0.90 (t, J = 7.0 Hz, 3H, CH3) 
ppm; 13C NMR {1H} (75 MHz, CDCl3) δC 176.2, 85.1, 78.4, 
77.5, 39.0, 36.8, 34.5, 28.3, 22.8, 14.1 ppm; HRMS (ESI): m/z 
[M+H]+ Calcd. for:C10H17O3: 185.1178, Found: 185.1172, 
[M+Na]+ Calcd. for C10H16NaO3: 207.0997, Found: 207.0992, 
[M+K]+ Calcd. for C10H16KO3: 223.0737, Found: 223.0730. 
rac-(1R,5R,7S)-7-nButyl-2,6-dioxabicyclo[3.3.0]octane-3-
one ((±)-18). The title compound was prepared according to 
general method 1 from diol (±)-17 (300 mg, 1.90 mmol). The 
purification of crude product by MPLC (hexanes/EtOAc: 100/0 
to 75/25 then isocratic hexanes/EtOAc: 75/25) provided desired 
lactone (±)-18 (189 mg, 54%, pale yellow oil). All physical and 
spectral data were in good agreement with the literature.18 Rf = 
0.20 (hexanes/EtOAc, 4:1); IR (ATR) νmax 2932, 1774, 1152, 
1067, 898 cm-1; 1H NMR (300 MHz, CDCl3) δH 5.01 (ddd, J = 
6.9, 4.4, 2.2 Hz, 1H, H-1), 4.54-4.46 (m, 1H, H-5), 3.99-3.87 
(m, 1H, H-7), 2.72 (d, J = 3.4 Hz, 2H, H-4), 2.48-2.36 (m, 1H, 
H-8a), 1.87 (ddd, J = 14.3, 7.9, 2.2 Hz, 1H, H-8b), 1.73-1.45 (m, 
2H, CH2(CH2)2CH3), 1.45-1.19 (m, 4H, CH2(CH2)2CH3), 0.89 
(t, J = 7.0 Hz, 3H, CH3) ppm; 13C NMR {1H} (75 MHz, CDCl3) 
δC 175.7, 84.8, 80.5, 78.4, 38.4, 36.5, 35.3, 28.3, 22.7, 14.1 ppm; 
HRMS (ESI): m/z [M+H]+ Calcd. for:C10H17O3: 185.1178, 
Found: 185.1172, [M+Na]+ Calcd. for C10H16NaO3: 207.0997, 
Found: 207.0992. 
(6-Methyltetrahydro-2H-pyran-2-yl) acetic acid ((±)-24). 
The title compounds were prepared according to general 
method 1 from alcohol (±)-23 (217 mg, 1.90 mmol. After 
evaporation of acetic acid the residue was dissolved in EtOAc 
(50 mL) and solution of HCl was added (w = 0.12, 25 mL). The 
organic phase was separated, and the aqueous phase was 
extracted with EtOAc (9x50 mL). The combined organic phases 
were dried over Na2SO4, filtered and concentrated in vacuo. The 
purification of crude product by MPLC (hexanes/EtOAc: 100/0 
to 50/50 then isocratic hexanes/EtOAc: 50/50) provided desired 
acids (±)-syn-24 (198, 66%, white solid) and (±)-anti-24 (66, 
22%, colourless oil). According to general method 2 in 172 min. 
long run 1.52 g (53%) of (±)-syn-24 and 0.79 g (30%) of (±)-
anti-24 were obtained. All physical and spectral data were in 
good agreement with the literature.33 (±)-syn-24: Rf = 0.20 
(hexanes/EtOAc, 1:1); mp 56.3-56.7 °C, lit.34 mp 54-55 °C; IR 
(ATR) νmax 2941, 1707, 1226, 1076, 937 cm-1 1H NMR (300 
MHz, CDCl3) δH 3.83-3.71 (m, 1H, H-6), 3.63-3.49 (m, 1H, H-
2), 2.57 (dd, J = 16.0, 7.2 Hz, 1H, Ha from CH2CO), 2.51 (dd, J 
= 16.0, 5.3 Hz, 1H, Hb from CH2CO), 1.91-1.78 (m, 1H, H-3a), 
1.64 (tdd, J = 5.9, 4.5, 2.7 Hz, 2H, H-3b and H-5b), 1.59-1.46 
(m, 1H, H-5a), 1.37-1.23 (m, 2H, H-4), 1.21 (d, J = 6.2 Hz, 3H, 
CH3) ppm; 13C NMR {1H} (75 MHz, CDCl3) δC 175.3, 74.7, 
74.1, 41.4, 32.9, 30.9, 23.3, 22.1 ppm; HRMS (ESI): m/z 
[M+H]+ Calcd. for:C8H15O3: 159.1021, Found: 159.1017, 
[M+Na]+ Calcd. for C8H14NaO3: 181.0841, Found: 181.0836, 
[M+K]+ Calcd. for C8H14KO3: 197.0580, Found: 197.0573; (±)-
anti-24: Rf = 0.15 (hexanes/EtOAc, 1:1); IR (ATR) νmax 2920, 
1705, 1440, 1086, 902 cm-1; 1H NMR (300 MHz, CDCl3) δH 
4.24 (ddd, J = 12.3, 8.0, 4.7 Hz, 1H, H-2), 4.08-3.95 (m, 1H, H-
6), 2.69 (dd, J = 15.3, 8.0 Hz, 1H, Ha from CH2CO), 2.46 (dd, J 
= 15.3, 4.7 Hz, 1H, Hb from CH2CO), 1.78-1.60 (m, 4H, H-5 
and H-3), 1.44-1.28 (m, 2H, H-4), 1.21 (d, J = 6.5 Hz, 3H, CH3) 
ppm; 13C NMR {1H} (75 MHz, CDCl3) δC 175.8, 68.2, 67.7, 
39.0, 31.0, 29.8, 19.2, 18.1 ppm; HRMS (ESI): m/z [M+H]+ 
Calcd. for:C8H15O3: 159.1021, Found: 159.1019, [M+Na]+ 
Calcd. for C8H14NaO3: 181.0841, Found: 181.0837, [M+K]+ 
Calcd. for C8H14KO3: 197.0580, Found: 197.0576. 
Synthesis of starting materials 
(S)-1-((R)-Oxiran-2-yl)prop-2-en-1-ol (26). To a suspension 
of crushed molecular sieves (9.80 g, 4Å) in anhydrous CH2Cl2 
(383 mL) was added dropwise the solution of L-(+)-DET (8.0 
mL, 46.55 mmol, 0.24 equiv) in anhydrous CH2Cl2 (11.5 mL) 
at -25 °C followed by a solution of Ti(OiPr)4 (11.5 mL, 38.79 
mmol, 0.2 equiv) in anhydrous CH2Cl2 (11.5 mL). After 30 min. 
of stirring at same temperature the solution of tBuOOH (23.3 
mL, 13.3 M in anhydrous CH2Cl2, 310.36 mmol, 1.6 equiv) was 
added dropwise and mixture was left to stir for another 15 min. 
Then the solution of divinylcarbinol 25 (16.32 g, 193.97 mmol, 
1 equiv) in anhydrous CH2Cl2 (6 mL) was added and resulting 
mixture was stirred at -25 °C for 10 days. Subsequently, 
solution of tartaric acid (25 g, 168.76 mmol, 0.87 equiv) in 
water (63 mL) was added and the biphasic mixture was left to 
warm to room temperature under vigorous stirring. After 
 
filtering of insoluble particles, the organic phase was separated, 
and aqueous one was extracted with CH2Cl2 (3x100 mL). The 
combined organic extracts were dried over Na2SO4, filtered and 
concentrated in vacuo. Distillation of the residue (23 mbar, 60-
75 °C) provided desired epoxide 26 (9.90 g, colorless oil) in 
51% yield. All physical and spectral data were in good 
agreement with the literature.35 Rf = 0.30 (hexanes/EtOAc, 
13:7); [α]D
20
 +58.1 (c 1.70, CHCl3); IR (ATR) νmax 3406, 1251, 
930, 885, 466 cm-1; 1H NMR (300 MHz, CDCl3) δH 5.85 (ddd, 
J = 17.1, 10.5, 6.2 Hz, 1H, H-4), 5.39 (dt, J = 17.1, 1.3 Hz, 1H, 
H-5a), 5.26 (dt, J = 10.5, 1.3 Hz, 1H, H-5b), 4.38-4.29 (m, 1H, 
H-3), 3.09 (ddd, J = 6.0, 3.9, 2.9 Hz, 1H, H-2), 2.80 (dd, J = 5.0, 
2.9 Hz, 1H, H-1a), 2.75 (dd, J = 5.0, 3.9 Hz, 1H, H-1b), 2.06 (s, 
1H, OH) ppm; 13C NMR{1H} (75 MHz, CDCl3) δC 135.6, 
117.8, 70.3, 54.0, 43.6 ppm; HRMS (ESI): m/z [M+H]+ Calcd. 
for:C5H9O2: 101.0603, Found: 101.0597, [M+Na]+ Calcd. for 
C5H8NaO2: 123.0422, Found: 123.0416. 
(2R,3S)-Pent-4-ene-1,2,3-triol (1). Epoxide 26 (10.15 g, 
101.38 mmol, 1 equiv) was dissolved in the solution of AcOH 
(2 mL, 35.48 mmol, 0.35 equiv) in water (338 mL). This 
mixture was stirred overnight at 60 °C and then concentrated in 
vacuo. The crude product (11.18 g, 93%, colorless oil) was used 
without further purification. All physical and spectral data were 
in good agreement with the literature.35 Rf = 0.15 
(CH2Cl2/MeOH, 17:3); [α]D
20
 -25.8 (c 1.35, MeOH); IR (ATR) 
νmax 3316, 1423, 1026, 992, 468 cm-1; 1H NMR (300 MHz, 
CD3OD) δH 6.01 (ddd, J =17.2, 10.5, 6.5 Hz, 1H, H-4), 5.32 
(ddd, J = 17.2, 1.9, 1.4 Hz, 1H, H-5a), 5.21 (ddd, J = 10.5, 1.9, 
1.4 Hz, 1H, H-5b), 4.07 (ddd, J = 6.5, 2.7, 1.4 Hz, 1H, H-3), 
3.73-3.64 (m, 1H, H-2), 3.63-3.53 (m, 2H, H-1) ppm; 13C 
NMR{1H} (75 MHz, CD3OD) δC 139.1, 116.4, 76.0, 74.9, 64.4 
ppm; HRMS (ESI): m/z [M+Na]+ Calcd. for C5H10NaO3: 
141.0528, Found: 141.0523. 
(2R,3S)-1-Aminopent-4-ene-2,3-diol (27). A mixture of 
epoxide 26 (1.4 g, 13.98 mmol, 1 equiv) and ammonia (15 mL, 
25% wt in water) was stirred overnight at room temperature and 
then concentrated in vacuo. The crude product (1.64 g, 82%, 
colorless oil) was used without further purification. All physical 
and spectral data were in good agreement with the literature.36 
Rf = 0.10 (CH2Cl2/MeOH, 17:3); [α]D
20
 -36.0 (c 0.71, CHCl3); IR 
(ATR) νmax 3084, 1645, 1570, 991, 928 cm-1; 1H NMR (300 
MHz, CD3OD) δH 5.97 (ddd, J =17.3, 10.5, 6.1 Hz, 1H, H-4), 
5.30 (ddd, J = 17.3, 1.9, 1.5 Hz, 1H, H-5a), 5.18 (ddd, J = 10.5, 
1.9, 1.3 Hz, 1H, H-5b), 3.97 (dddd, J = 6.1, 5.9, 1.5, 1.3 Hz, 1H, 
H-3), 3.44 (ddd, J = 7.9, 5.9, 3.5 Hz, 1H, H-2), 2.81 (dd, J = 
13.2, 3.5 Hz, 1H, H-1a), 2.64 (dd, J = 13.2, 7.9 Hz, 1H, H-1b) 
ppm; 13C NMR{1H} (75 MHz, CD3OD) δC 139.4, 116.4, 76.2, 
76.0, 44.7 ppm; HRMS (ESI): m/z [M+H]+ Calcd. 
for:C5H12NO2: 118.0868, Found: 118.0865. 
tert-Butyl (2R,3S)-2,3-dihydroxypent-4-enylcarbamate (3a). 
To a solution of amino alcohol 27 (1.33 g, 11.35 mmol, 1 equiv) 
in MeOH (26.4 mL) was added Et3N (8.9 mL, 63.58 mmol, 5.6 
equiv) and the mixture was left to stir for 10 min. Subsequently, 
Boc2O (3.15 g, 14.42 mmol, 1.27 equiv) was added portion wise 
and the resulting mixture was stirred at room temperature 
overnight. After concentration in vacuo, the residue was 
purified by MPLC (hexanes/EtOAc: 100/0 to 50/50 then 
isocratic hexanes/EtOAc: 50/50) providing desired product 3a 
(1.76 g, white solid) in 71% yield. All physical and spectral data 
were in good agreement with the literature.15d Rf = 0.20 
(hexanes/EtOAc, 1:1); mp 71.2-71.7 °C; [α]D
20
 -14.9 (c 2.20, 
MeOH); IR (ATR) νmax 3296, 1677, 1549, 1073, 669 cm-1; 1H 
NMR (300 MHz, CDCl3) δH 5.92 (ddd, J = 17.1, 10.5, 6.0 Hz, 
1H, H-4), 5.37 (dt, J = 17.1, 1.4 Hz, 2H, H-5a), 5.32-5.21 (m, 
1H, H-5b), 5.12 (s, 1H, NH), 4.05 (tt, J = 6.0, 1.4 Hz, 2H, H-3), 
3.61 (td, J = 6.0, 3.4 Hz, 1H, H-2), 3.39 (dd, J = 14.7, 6.0 Hz, 
2H, H-1a), 3.27 (dd, J = 14.7, 3.4 Hz, 1H, H-1b), 3.06 (s, 2H, 
OH), 1.44 (s, 9H, CH(CH3)3) ppm; 13C NMR{1H} (75 MHz, 
CDCl3) δC 157.8, 136.8, 117.5, 80.3, 74.0, 73.9, 42.4, 28.5 ppm; 
HRMS (ESI): m/z [M+H]+ Calcd. for:C10H20NO4: 218.1392, 
Found: 218.1387, [M+Na]+ Calcd. for C10H19NNaO4: 240.1212, 
Found: 240.1206, [M+K]+ Calcd. for C10H19KNO4: 256.0951, 
Found: 256.0945. 
Benzyl (2R,3S)-2,3-dihydroxypent-4-enylcarbamate (3b). To 
a solution of amino alcohol 27 (1.24 g, 9.48 mmol, 1 equiv) and 
NaHCO3 (1.83 g, 21.81 mmol, 2.3 equiv) in H2O (20 mL) was 
added dropwise CbzCl (2.3 mL, 14.23 mmol, 1.5 equiv) at 0 °C. 
The resulting mixture was stirred at same temperature for 5h. 
Reaction mixture was then extracted with CHCl3 (2x15 mL), 
the combined organic extracts were dried over Na2SO4, filtered 
and concentrated in vacuo. Crystallization of the crude material 
from the mixture hexanes/EtOAc = 1/2 provided protected 
aminodiol 3b (1.17 g, white solid) in 62% yield. All physical 
and spectral data were in good agreement with the literature.37 
Rf = 0.15 (hexanes/EtOAc, 1:1); mp 93.8-94.0 °C, lit.37 mp 
93 °C; [α]D
20
 +1.1 (c 1.52, MeOH); IR (ATR) νmax 3318, 1688, 
1541, 1003, 696 cm-1; 1H NMR (300 MHz, CDCl3) δH 7.43-7.27 
(m, 5H, HAr), 5.91 (ddd, J = 17.2, 10.5, 6.4 Hz, 1H, H-4), 5.36 
(dt, J = 17.2, 1.4 Hz, 1H, H-5a), 5.31-5.25 (m, 1H, H-5b), 5.24 
(s, 1H, NH), 5.12 (s, 2H, PhCH2), 4.11-4.02 (m, 1H, H-3), 3.65 
(dd, J = 9.5, 5.0 Hz, 1H, H-2), 3.50-3.31 (m, 2H, H-1), 2.95 (s, 
1H, OH), 2.65 (s, 1H, OH) ppm; 13C NMR{1H} (75 MHz, 
CDCl3) δC 158.0, 136.6, 136.3, 128.7, 128.4, 128.3, 117.9, 74.1, 
73.5, 67.3, 42.7 ppm; HRMS (ESI): m/z [M+H]+ Calcd. 
for:C13H18NO4: 252.1236, Found: 252.1230, [M+Na]+ Calcd. 
for C13H17NNaO4: 274.1055, Found: 274.1049, [M+K]+ Calcd. 
for C13H17KNO4: 290.0795, Found: 290.0788. 
N-((2R,3S)-2,3-Dihydroxypent-4-enyl)-4-
methylbenzenesulfonamide (3c). To a solution of amino alcohol 
27 (3.66 g, 31.2 mmol, 1 equiv) in pyridine (18.3 mL) was 
added TsCl (5.96 g, 31.24 mmol, 1 equiv) at 0 °C. The mixture 
was left to warm to room temperature and stirred for next 18 h. 
Pyridine was concentrated in vacuo; the residue was suspended 
in EtOAc (20 mL) and filtered through short pad of silica gel. 
Pad was then washed using EtOAc (100 mL) and filtrate was 
concentrated in vacuo. The crude product was purified by 
MPLC (hexanes/EtOAc: 100/0 to 30/70 then isocratic 
hexanes/EtOAc: 30/70) providing desired product 3c (5.92 g, 
70%, white solid). All physical and spectral data were in good 
agreement with the literature.26 Rf = 0.20 (hexanes/EtOAc, 3:7); 
mp 93.0-93.4 °C, lit.26 mp 67-70 °C; [α]D
20
 +8,8 (c 0.80; CHCl3); 
IR (ATR) νmax 3430, 3127, 1305, 1153, 544 cm-1; 1H NMR (300 
MHz, CDCl3) δH 7.77-7.69 (m, 2H, HAr), 7.30 (dd, J = 8.5, 0.6 
Hz, 2H, HAr), 5.82 (ddd, J = 17.2, 10.5, 6.1 Hz, 1H, H-4), 5.50-
5.37 (m, 1H, NH), 5.32 (dt, J = 17.2, 1.4 Hz, 1H, H-5a), 5.22 
(dt, J = 10.5, 1.4 Hz, 1H, H-5b), 4.21 (ddt, J = 6.1, 4.9, 1.4 Hz, 
1H, H-3), 3.70 (ddd, J = 7.0, 4.9, 3.5 Hz, 1H, H-2), 3.12 (ddd, 
J = 13.3, 7.0, 3.5 Hz, 1H, H-1a), 3.07-2.95 (m, 1H, H-1b), 2.83 
(s, 2H, OH), 2.42 (s, 3H, CH3) ppm; 13C NMR{1H} (75 MHz, 
CDCl3) δC 143.8, 136.6, 136.1, 129.9, 127.2, 117.9, 74.3, 72.4, 
44.5, 21.7 ppm; HRMS (ESI): m/z [M+H]+ Calcd. 
for:C12H18NO4S: 272.0957, Found: 272.0951, [M+Na]+ Calcd. 
for C12H17NNaO4S: 294.0776, Found: 294.0770, [M+K]+ 
Calcd. for C12H17KNO4S: 310.0515, Found: 310.0509. 
 
Ethyl 3-hydroxypent-4-enoate (28). To a solution of 
LiHMDS (41.78 g, 249.70 mmol, 1.1 equiv) in anhydrous THF 
(400 mL) was added dropwise anhydrous EtOAc (22.3 mL, 
227.00 mmol, 1 equiv) at -78 °C. The reaction mixture was 
stirred for 20 min at same temperature. Subsequently, a solution 
of freshly distilled acrolein (22.8 mL, 340.50 mmol, 1.5 equiv) 
in anhydrous THF (100 mL) was added dropwise over period 
of 30 min. The resulting mixture was stirred for 1 h at -78 °C, 
then it was left to warm to 0 °C and quenched by addition of 
saturated aqueous solution of NH4Cl (300 mL). After 
concentration under vacuum to the 1/5 of previous volume Et2O 
(400 mL) was added. Organic phase was separated, and aqueous 
phase was extracted with Et2O (3x200 mL). The combined 
organic extracts were dried over Na2SO4, filtered and 
concentrated in vacuo. Distillation of a residue (4 mbar, 75-76 
°C) provided desired hydroxyketone 28 (26.01 g, 79%, 
colorless oil). All physical and spectral data were in good 
agreement with the literature.38 Rf = 0.30 (hexanes/EtOAc, 7:3); 
IR (ATR) νmax 3292, 1446, 962, 634, 546 cm-1; 1H NMR (300 
MHz, CDCl3) δH 5.88 (ddd, J = 17.2, 10.5, 5.5 Hz, 1H, H-4), 
5.31 (dt, J = 17.2, 1.3 Hz, 1H, H-5a), 5.15 (dt, J = 10.5, 1.3 Hz, 
1H, H-5b), 4.58-4.48 (m, 1H, H-3), 4.17 (q, J = 7.1 Hz, 2H, 
CH2CH3), 2.99 (s, 1H, OH), 2.58 (dd, J = 16.2, 4.4 Hz, 1H, H-
2a), 2.50 (dd, J = 16.2, 8.0 Hz, 1H, H-2b), 1.27 (t, J = 7.1 Hz, 
3H, CH2CH3) ppm; 13C NMR{1H} (75 MHz, CDCl3) δC 172.4, 
138.9, 115.5, 69.1, 60.9, 41.3, 14.3 ppm; HRMS (ESI): m/z 
[M+H]+ Calcd. for:C7H13O3: 145.0865, Found: 220.1331, 
[M+Na]+ Calcd. for C7H12NaO3: 167.0684, Found: 167.0678. 
Pent-4-ene-1,3-diol ((±)-5). To a solution of ethyl ester 28 
(3.42 g, 23.69 mmol, 1 equiv) in anhydrous CH2Cl2 (40 mL) 
was added imidazole (3.23 g, 47.38 mmol, 2 equiv) and TBSCl 
(4.46 g, 29.61 mmol, 1.25 equiv) at 0 °C. The mixture was left 
to stir at room temperature for 15h. Subsequently, the resulting 
suspension was washed with deionized water (3x15 mL). 
Organic phase was dried over Na2SO4, filtered and concentrated 
in vacuo. The crude product was dissolved in anhydrous THF 
(93 mL) and a solution of DiBAl-H (53.4 mL, 1 M in CH2Cl2, 
53.40 mmol, 2.3 equiv) was added dropwise at 0 °C. Resulting 
mixture was left to warm to 15 °C over a period of 1 hour and 
then cooled to 0 °C again. Subsequently, saturated solution of 
Rochelle salt (20 mL) was added and this emulsion was stirred 
for 5 h at room temperature. Organic phase was separated, and 
aqueous phase was extracted with Et2O (3x90 mL). Combined 
organic phases were dried over Na2SO4, filtered and 
concentrated in vacuo. The crude product (3-(tert-
butyldimethylsilyloxy)pent-4-en-1-ol) (31) was dissolved in 
MeOH (75 mL) and DOWEX marathon H+ form (13.5 g) was 
added. This suspension was left to stir at room temperature until 
full conversion was observed (overnight). Filtration of 
DOWEX residues was followed by concentration in vacuo. The 
crude product was purified by MPLC using gradient 
(hexanes/EtOAc: 100/0 to 35/65 then isocratic hexanes/EtOAc: 
35/65) providing desired product (±)-5 (1.45 g, 60% over 3 
steps, colorless oil). All physical and spectral data were in good 
agreement with the literature.39 Rf = 0.20 (hexanes/EtOAc, 3:7); 
IR (ATR) νmax 3317, 1422, 1049, 922, 663 cm-1; 1H NMR (300 
MHz, CDCl3) δH 6.00-5.83 (m, 1H, H-4), 5.28 (d, J = 17.2 Hz, 
1H, H-5a), 5.14 (d, J = 10.4 Hz, 1H, H-5b), 4.41 (dt, J = 11.5, 
5.7 Hz, 1H, H-3), 3.95-3.75 (m, 2H, H-1), 2.50 (s, 2H, OH), 
1.91-1.66 (m, 2H, H-2) ppm; 13C NMR{1H} (75 MHz, CDCl3) 
δC 140.7, 114.8, 72.9, 61.2, 38.3 ppm; HRMS (ESI): m/z 
[M+Na]+ Calcd. for:C5H10NaO2: 125.0579, Found: 125.0573. 
2-Methylhex-5-ene-2,4-diol ((±)-7). To a solution of ethyl 
ester 28 (17.75 g, 123.12 mmol, 1 equiv) in anhydrous CH2Cl2 
(205 mL) was added imidazole (16.76 g, 246.24 mmol, 2 equiv) 
and TBSCl (23.20 g, 153.90 mmol, 1.25 equiv) at 0 °C. The 
mixture was left to warm to room temperature and stirred until 
full conversion was observed (overnight)., After washing with 
deionized water (3x80 mL), organic phase was dried over 
Na2SO4, filtered and concentrated in vacuo. The crude product 
(quantitative yield) was used without further purification. To 
the solution of crude ethyl 3-tert-butyldimethylsilyloxy)pent-4-
enoate (29) (14.31 g, 55.37 mmol, 1 equiv) in anhydrous THF 
(222 mL) was added dropwise solution of MeMgBr (46.2 mL, 
3 M in Et2O, 138.43 mmol, 2.5 equiv) at -78 °C. The resulting 
mixture was stirred for 30 min at this temperature and then left 
to warm to room temperature (90 min). The reaction was 
quenched with saturated solution of NH4Cl (150 ml) and diluted 
with Et2O (240 mL). Organic phase was separated, and aqueous 
phase was extracted with Et2O (3x240 mL). Combined organic 
phases were dried over Na2SO4, filtered and concentrated in 
vacuo. The crude product (4-(tert-butyldimethylsilyloxy)-2-
methylhex-5-en-2-ol (30), quantitative yield) was dissolved in 
MeOH (300 mL) and DOWEX marathon H+ form (30.60 g) was 
added. This suspension was left to stir at room temperature until 
full conversion was observed (overnight). Filtration of 
DOWEX residues was followed by concentration in vacuo. The 
crude product was purified by MPLC using gradient 
(hexanes/EtOAc: 100/0 to 65/35 then isocratic hexanes/EtOAc: 
65/35) providing desired product (±)-7 (6.16 g, 87% over 3 
steps, colorless oil). All physical and spectral data were in good 
agreement with the literature.40 Rf = 0.20 (hexanes/EtOAc, 7:3); 
IR (ATR) νmax 3330, 1381, 1150, 910, 526 cm-1; 1H NMR (300 
MHz, CDCl3) δH 5.84 (ddd, J = 17.2, 10.4, 5.9 Hz, 1H, H-5), 
5.23 (dt, J = 17.2, 1.4 Hz, 1H, H-6a), 5.07 (dt, J = 10.4, 1.5 Hz, 
1H, H-6b), 4.49 (dddt, J = 10.8, 5.9, 2.6, 1.4 Hz, 1H, H-4), 3.42 
(s, 2H, OH), 1.71 (dd, J = 14.6, 10.8 Hz, 1H, H-3a), 1.55 (dd, J 
= 14.6, 2.6 Hz, 1H, H-3b), 1.32 (s, 3H, H-1), 1.25 (s, 3H, CH3) 
ppm; 13C NMR{1H} (75 MHz, CDCl3) δC 141.1, 114.3, 71.7, 
71.0, 47.7, 31.9, 27.8 ppm; HRMS (ESI): m/z [M+Na]+ Calcd. 
for C7H14NaO2: 153.0892, Found: 153.0887. 
3-Hydroxypent-4-enenitrile (32). To a solution of iPr2NH 
(23.48 mL, 214.36 mmol, 1.6 equiv) in anhydrous THF (268 
mL) was added dropwise solution of nBuLi (126 mL, 1.6 M in 
hexanes, 201.0 mmol, 1.6 equiv) at -78 °C. The mixture was left 
to stir for 30 min and then solution of acetonitrile (7 mL, 133.98 
mmol, 1 equiv) in anhydrous THF (67 mL) was added dropwise 
at the same temperature. After stirring over period 1 hour at -78 
°C, solution of acrolein (10.8 mL, 160.77 mmol, 1.2 equiv) in 
anhydrous THF (54 mL) was added dropwise and resulting 
mixture was stirred for 2.5 h. The reaction mixture was 
quenched with saturated solution of NH4Cl (150 mL) and 
diluted with Et2O (200 mL). Subsequently, organic phase was 
separated, and aqueous phase was extracted with Et2O (3x300 
mL). The combined organic extracts were dried over Na2SO4, 
filtered and concentrated in vacuo. Distillation of a residue (6-
7 mbar, 80-83 °C) provided desired nitrile 32 (9.7 g, 74%, pale 
yellow oil). All physical and spectral data were in good 
agreement with the literature.41 Rf = 0.60 (hexanes/EtOAc, 1:1); 
IR (ATR) νmax 3417, 1415, 1053, 932, 491 cm-1; 1H NMR (300 
MHz, CDCl3) δH 5.92 (ddd, J = 17.1, 10.4, 5.9 Hz, 1H, H-4), 
5.47-5.36 (m, 1H, H-5a), 5.33-5.27 (m, 1H, H-5b), 4.52-4.41 (m, 
1H, H-3), 2.64 (dd, J = 15.8, 4.8 Hz, 1H, H-2a), 2.57 (dd, J = 
15.8, 5.4 Hz, 1H, H-2b), 2.30 (s, 1H, OH) ppm; 13C NMR{1H} 
(75 MHz, CDCl3) δC 137.4, 117.6, 117.4, 68.6, 26.1 ppm; 
 
HRMS (ESI): m/z [M+H]+ Calcd. for:C5H8NO: 98.0606, 
Found: 98.0599, [M+Na]+ Calcd. for C5H7NNaO: 120.0425, 
Found: 120.0418. 
5-Aminopent-1-en-3-ol (33). To a solution of nitrile 32 (9 g, 
92.67 mmol, 1 equiv) in anhydrous THF (185 mL) was portion-
wise added LAH (5.56 g, 146.42 mmol, 1.58 equiv) at 0 °C. The 
reaction was left to warm to room temperature and stirred until 
full conversion was observed (overnight). Subsequently 
Na2SO4 . 10 H2O (179 g, 556.04 mmol, 6 equiv) and celite (60 
g) were added and this suspension was diluted with CH2Cl2 (200 
mL). After next 2 h of stirring, solids were filtered and washed 
with CH2Cl2 (200 mL). The filtrate was dried over Na2SO4, 
filtered and concentrated in vacuo. Distillation of crude product 
(13 mbar, 90 °C) provided desired amino alcohol 33 (2.53 g, 
27%, yellow oil). All physical and spectral data were in good 
agreement with the literature.42 Rf = 0.10 (EtOAc). IR (ATR) 
νmax 3358, 2933, 1425, 917, 671 cm-1; 1H NMR (300 MHz, 
CDCl3) δH 5.87 (ddd, J = 17.1, 10.4, 5.2 Hz, 1H, H-2), 5.27 (dt, 
J = 17.1, 1.6 Hz, 1H, H-1a), 5.08 (dt, J = 10.4, 1.6 Hz, 1H, H-
1b), 4.35 (dddd, J = 7.0, 5.2, 3.7, 1.6 Hz, 1H, H-3), 3.09 (ddd, J 
= 12.2, 6.1, 4.0 Hz, 1H, H-5a), 2.95-2.83 (m, 1H, H-5b), 2.57 (s, 
3H, NH2 and OH), 1.70 (ddt, J = 13.9, 6.1, 4.0 Hz, 1H, H-4a), 
1.62-1.47 (m, 1H, H-4b) ppm; 13C NMR{1H} (75 MHz, CDCl3) 
δC 141.3, 113.9, 73.8, 40.3, 37.7 ppm; HRMS (ESI): m/z 
[M+H]+ Calcd. for:C5H12NO: 102.0919, Found: 102.0913, 
[M+Na]+ Calcd. for C5H11NNaO: 124.0738, Found: 124.0734. 
tert-Butyl 3-hydroxypent-4-enylcarbamate ((±)-9a). To 
a solution of amino alcohol 33 (0.80 g, 7.91 mmol, 1 equiv) in 
CH2Cl2 (40 mL) was added dropwise solution of Boc2O (2.21 
g, 10.12 mmol, 1.28 equiv) and Et3N (1.32 mL, 9.49 mmol, 1.2 
equiv) in CH2Cl2 (20 mL) at 0 °C. After stirring for 15h at room 
temperature was resulting mixture concentrated in vacuo. 
Residue was purified by MPLC (hexanes/EtOAc: 100/0 to 
65/35 then isocratic hexanes/EtOAc: 65/35) providing desired 
product (±)-9a (1.37 g, 86%, colorless oil). All physical and 
spectral data were in good agreement with the literature.43 Rf = 
0.20 (hexanes/EtOAc, 13:7); IR (ATR) νmax 3367, 2978, 1681, 
1166, 990 cm-1; 1H NMR (300 MHz, CDCl3) δH 5.89 (ddd, J = 
17.2, 10.5, 5.5 Hz, 1H, H-4), 5.26 (dt, J = 17.2, 1.5 Hz, 1H, H-
5a), 5.10 (dt, J = 10.5, 1.5 Hz, 1H, H-5b), 4.86 (s, 1H, NH), 4.18 
(ddd, J = 10.0, 5.5, 1.5 Hz, 1H, H-3), 3.52-3.31 (m, 1H, H-1a), 
3.22-3.08 (m, 1H, H-1b), 2.93 (s, 1H, OH), 1.79-1.53 (m, 2H, 
H-2), 1.44 (s, 9H, C(CH3)3) ppm; 13C NMR{1H} (75 MHz, 
CDCl3) δC 157.0, 140.6, 114.5, 79.7, 70.3, 37.5, 37.3, 28.5 ppm; 
HRMS (ESI): m/z [M+H]+ Calcd. for:C10H20NO3: 202.1443, 
Found: 202.1439, [M+Na]+ Calcd. for C10H19NNaO3: 224.1263, 
Found: 224.1258, [M+K]+ Calcd. for C10H19KNO3: 240.1002, 
Found: 240.0997. 
Benzyl 3-hydroxypent-4-enylcarbamate ((±)-9b). To 
a solution of amino alcohol 33 (0.81 g, 8.03 mmol, 1 equiv) and 
Et3N (1.4 mL, 10.04 mmol, 1.25 equiv) in anhydrous THF (50 
mL) was added dropwise CbzCl (1.38 g, 9.61 mmol, 1.2 equiv) 
at -15 °C. The reaction mixture was left to stir at room 
temperature for 15h. Subsequently, the saturated solution of 
NaCl was added (50 mL), organic phase was separated, and 
aqueous phase was extracted with Et2O (3x50 mL). Combined 
organic extracts were dried over Na2SO4, filtered and 
concentrated in vacuo. Purification of residuum by MPLC 
(hexanes/EtOAc: 100/0 to 50/50 then isocratic hexanes/EtOAc: 
50/50) provided desired product (±)-9b (0.94 g, 50%, colorless 
oil). All physical and spectral data were in good agreement with 
the literature.44 Rf = 0.20 (hexanes/EtOAc, 1:1); IR (ATR) νmax 
3325, 1692, 1518, 1257, 695 cm-1; 1H NMR (300 MHz, CDCl3) 
δH 7.39-7.28 (m, 5H, HAr), 5.88 (ddd, J = 17.1, 10.5, 5.8 Hz, 1H, 
H-4), 5.25 (dt, J = 17.1, 1.4 Hz, 1H, H-5a), 5.12 (dt, J = 10.5, 
1.4 Hz, 1H, H-5b), 5.12-5.07 (m, 3H, NH and Ph-CH2), 4.21 
(dddd, J = 8.7, 5.8, 2.9, 1.4 Hz, 1H, H-3), 3.59-3.40 (m, 1H, H-
1a), 3.33-3.19 (m, 1H, H-1b), 2.13 (s, 1H, OH), 1.83-1.57 (m, 
2H, H-2) ppm; 13C NMR{1H} (75 MHz, CDCl3) δC 157.1, 
140.5, 136.6, 128.7, 128.3, 128.2, 114.8, 70.8, 66.9, 37.9, 37.0 
ppm; HRMS (ESI): m/z [M+H]+ Calcd. for:C13H18NO3: 
236.1287, Found: 236.1281, [M+Na]+ Calcd. for C13H17NNaO3: 
258.1106, Found: 258.1100, [M+K]+ Calcd. for C13H17KNO3: 
274.0846, Found: 274.0840. 
N-(3-Hydroxypent-4-enyl)-4-methylbenzenesulfonamide 
((±)-9c). To a solution of amino alcohol 33 (0.81 g, 8.01 mmol, 
1 equiv) in pyridine (16 mL) was added TsCl (1.53 g, 8.01 
mmol, 1 equiv) at 0 °C. The mixture was stirred at room 
temperature for 3h and pyridine was removed in vacuo. 
Obtained residue was purified by MPLC (isocratic 
CH2Cl2/MeOH: 99/1) providing desired product (±)-9c (1.14 g, 
56%, white solid). All physical and spectral data were in good 
agreement with the literature.43 Rf = 0.20 (hexanes/EtOAc, 4:6); 
mp 70.2-70.8 °C, lit.43 mp 70.0-71.5 °C; IR (ATR) νmax 3274, 
1425, 1319, 1154, 549 cm-1; 1H NMR (300 MHz, CDCl3) δH 
7.74 (d, J = 8.2 Hz, 2H, HAr), 7.30 (d, J = 8.2 Hz, 2H, HAr), 5.79 
(ddd, J = 17.1, 10.6, 5.8 Hz, 1H, H-4), 5.24 (s, 1H, NH), 5.18 
(dt, J = 17.1, 1.2 Hz, 1H, H-5a), 5.08 (dt, J = 10.6, 1.2 Hz, 1H, 
H-5b), 4.27-4.20 (m, 1H, H-3), 3.18-3.10 (m, 1H, H-1a), 3.03 
(td, J = 12.3, 5.2 Hz, 1H, H-1b), 2.42 (s, 3H, CH3), 2.07 (s, 1H, 
OH), 1.73 (dddd, J = 16.9, 8.0, 5.2, 4.1 Hz, 1H, H-2a), 1.66-1.58 
(m, 1H, H-2b) ppm; 13C NMR{1H} (75 MHz, CDCl3) δC 143.5, 
140.1, 137.1, 129.8, 127.3, 115.3, 71.9, 40.7, 35.6, 21.7 ppm; 
HRMS (ESI): m/z [M+H]+ Calcd. for:C12H18NO3S: 256.1007, 
Found: 256.1001, [M+Na]+ Calcd. for C12H17NNaO3S: 
278.0827, Found: 278.0822, [M+K]+ Calcd. for C12H17KNO3S: 
294.0566, Found: 294.0560. 
3-Hydroxyundec-1-en-5-one (34). To a solution of iPr2NH 
(4.9 mL, 44.77 mmol, 1.4 equiv) in anhydrous THF (65 mL) 
was added dropwise solution of nBuLi (26 mL, 1.6 M in 
hexanes, 41.57 mmol, 1.3 equiv) at -78 °C. The mixture was left 
to stir for 30 min and then solution of octan-2-one (5 mL, 
31.98 mmol, 1 equiv) in anhydrous THF (16 mL) was added 
dropwise at the same temperature. After stirring over period of 
1 h at -78 °C, solution of acrolein (2.4 mL, 35.18 mmol, 1.1 
equiv) in anhydrous THF (12 mL) was added dropwise and 
resulting mixture was stirred for 2.5 h. The reaction was 
quenched with saturated solution of NH4Cl (50 mL) and diluted 
with Et2O (50 mL). Subsequently, organic phase was separated, 
and aqueous phase was extracted with Et2O (3x100 mL). The 
combined organic extracts were dried over Na2SO4, filtered and 
concentrated in vacuo. Purification of crude product by MPLC 
(isocratic hexanes/EtOAc: 90/10) provided hydroxyketone 34 
(2.78 g, 49%, colorless oil). All physical and spectral data were 
in good agreement with the literature.18 Rf = 0.25 
(hexanes/EtOAc, 4:1); IR (ATR) νmax 2928, 1705, 1376, 990, 
525 cm-1; 1H NMR (300 MHz, CDCl3) δH 5.86 (ddd, J = 17.1, 
10.5, 5.5 Hz, 1H, H-2), 5.29 (dt, J = 17.1, 1.4 Hz, 1H, H-1a), 
5.13 (dt, J = 10.5, 1.4 Hz, 1H, H-1b), 4.59-4.55 (m, 1H, H-3), 
2.66 (dd, J = 17.4, 3.9 Hz, 1H, H-4a), 2.62 (dd, J = 17.4, 8.2 Hz, 
1H, H-4b), 2.43 (t, J = 7.4 Hz, 2H, H-6), 1.62-1.52 (m, 2H, H-
7), 1.36-1.22 (m, 6H, H-8, H-9 and H-10) 0.88 (t, J = 7.0 Hz, 
3H, CH3) ppm; 13C NMR{1H} (75 MHz, CDCl3) δC 211.7, 
139.2, 115.1, 68.8, 48.7, 43.9, 31.7, 29.0, 23.7, 22.6, 14.2 ppm; 
HRMS (ESI): m/z [M+H]+ Calcd. for:C11H21O2: 185.1542, 
 
Found: 185.1535, [M+Na]+ Calcd. for C11H20NaO2: 207.1361, 
Found: 207.1355. 
3-Hydroxynon-1-en-5-one (35). To a solution of iPr2NH (4.9 
mL, 44.77 mmol, 1.4 equiv) in anhydrous THF (65 mL) was 
added dropwise solution of nBuLi (26 mL, 1.6 M in hexanes, 
41.57 mmol, 1.3 equiv) at -78 °C. The mixture was left to stir 
for 30 min and then solution of hexan-2-one (3.9 mL, 31.98 
mmol, 1 equiv) in anhydrous THF (16 mL) was added dropwise 
at the same temperature. After stirring over period of 1 h at -78 
°C, solution of acrolein (2.4 mL, 35.18 mmol, 1.1 equiv) in 
anhydrous THF (12 mL) was added dropwise and resulting 
mixture was stirred for 1h. The reaction was quenched with 
saturated solution of NH4Cl (50 mL) and diluted with Et2O (50 
mL). Subsequently, organic phase was separated, and aqueous 
phase was extracted with Et2O (3x100 mL). The combined 
organic extracts were dried over Na2SO4, filtered and 
concentrated in vacuo. Purification of crude product by MPLC 
(isocratic hexanes/EtOAc: 90/10) provided hydroxyketone 35 
(2.06 g, 41%, colorless oil). All physical and spectral data were 
in good agreement with the literature.18 Rf = 0.25 
(hexanes/EtOAc, 4:1); IR (ATR) νmax 3421, 2933, 1704, 1379, 
991 cm-1; 1H NMR (300 MHz, CDCl3) δH 5.86 (ddd, J = 17.2, 
10.5, 5.4 Hz, 1H, H-2), 5.29 (dt, J = 17.2, 1.4 Hz, 1H, H-1a), 
5.13 (dt, J = 10.5, 1.4 Hz, 1H, H-1b), 4.61-4.53 (m, 1H, H-3), 
2.66 (dd, J = 17.4, 3.9 Hz, 1H, H-4a), 2.62 (dd, J = 17.4, 8.2 Hz, 
1H, H-4b), 2.44 (t, J = 7.5 Hz, 2H, H-6), 1.60-1.52 (m, 2H, H-
7), 1.37-1.26 (m, 2H, H-8), 0.91 (t, J = 7.4 Hz, 3H, CH3) ppm; 
13C NMR{1H} (75 MHz, CDCl3) δC 211.7, 139.2, 115.1, 68.8, 
48.7, 43.6, 25.8, 22.4, 14.0 ppm; HRMS (ESI): m/z [M+H]+ 
Calcd. for:C9H17O2: 157.1229, Found: 157.1222, [M+Na]+ 
Calcd. for C9H16NaO2: 179.1048, Found: 179.1044, [M+K]+ 
Calcd. for C9H16KO2: 195.0787, Found: 195.0783. 
rac-syn-Undec-1-ene-3,5-diol ((±)-11) and rac-anti-Undec-
1-ene-3,5-diol ((±)-15). Procedure A: To a suspension of 
NaBH4 (0.57 g, 14.92 mmol, 2.5 equiv) in benzene (36 mL) was 
added dropwise solution of hydroxyketone 34 (1.10 g, 5.97 
mmol, 1 equiv) in benzene (36 mL) at room temperature. After 
21 h of stirring a solution of HCl (2 M, 130 mL) and EtOAc 
(100 mL) were added. Organic phase was separated, and 
aqueous phase was extracted with EtOAc (5x100 mL). 
Combined organic phases were dried over Na2SO4 and 
concentrated in vacuo. The crude product was purified by 
MPLC (isocratic hexanes/EtOAc: 80/20) providing diols (±)-11 
(0.29 g, 26%, colorless oil) and (±)-15 (0.43g, 39%, colorless 
oil). All physical and spectral data were in good agreement with 
the literature.18 Procedure B: To a suspension of NaBH(OAc)3 
(6.33 g, 29.85 mmol, 5 equiv) in benzene (36 mL) was added 
dropwise solution of hydroxyketone 34 (1.10 g, 5.97 mmol, 1 
equiv) in benzene (36 mL) at room temperature. After 18h of 
stirring a solution of HCl (2 M, 30 mL) and EtOAc (100 mL) 
were added. Organic phase was separated, and aqueous phase 
was extracted with EtOAc (3x100 mL). Combined organic 
phases were dried over Na2SO4 and concentrated in vacuo. The 
crude product was purified by MPLC (isocratic 
hexanes/EtOAc: 80/20) providing diols (±)-11 (0.19 g, 17%, 
colorless oil) and (±)-15 (0,58 g, 52%, colorless oil). All 
physical and spectral data were in good agreement with the 
literature.18 (±)-11: Rf = 0.15 (hexanes/EtOAc, 4:1); IR (ATR) 
νmax 3346, 2927, 1712, 1457, 989 cm-1; 1H NMR (300 MHz, 
CDCl3) δH 5.89 (ddd, J = 17.2, 10.4, 5.9 Hz, 1H, H-2), 5.26 (dt, 
J = 17.2, 1.4 Hz, 1H, H-1a), 5.10 (dt, J = 10.4, 1.4 Hz, 1H, H-
1b), 4.43-4.33 (m, 1H, H-3), 3.95-3.82 (m, 1H, H-5), 2.44 (s, 
2H, OH), 1.72-1.19 (m, 12 H, H-4, H-6, H-7, H-8, H-9 and H-
10), 0.88 (t, J = 6.8 Hz, 3H, CH3) ppm; 13C NMR{1H} (75 MHz, 
CDCl3) δC 140.9, 114.6, 74.0, 72.7, 42.2, 38.3, 32.0, 29.4, 25.5, 
22.7, 14.2 ppm; HRMS (ESI): m/z [M+H]+ Calcd. for:C11H23O2: 
187.1698, Found: 187.1691, [M+Na]+ Calcd. for C11H22NaO2: 
209.1518, Found: 209.1513; (±)-15: Rf = 0.15 (hexanes/EtOAc, 
4:1); IR (ATR) νmax 3392, 2928, 1712, 1176, 1055 cm-1; 1H 
NMR (300 MHz, CDCl3) δH 5.94 (ddd, J = 17.2, 10.5, 5.4 Hz, 
1H, H-2), 5.30 (dt, J = 17.2, 1.5 Hz, 1H, H-1a), 5.15 (dt, J = 
10.5, 1.5 Hz, 1H, H-1b), 4.52-4.43 (m, 1H, H-3), 4.00-3.88 (m, 
1H, H-5), 2.07 (s, 2H, OH), 1.81-1.61 (m, 12H, H-4, H-6, H-7, 
H-8, H-9 and H-10), 0.88 (t, J = 6.8 Hz, 3H, CH3) ppm; 13C 
NMR{1H} (75 MHz, CDCl3) δC 140.9, 114.5, 70.9, 69.5, 42.3, 
37.8, 32.0, 29.4, 25.7, 22.8, 14.2 ppm; HRMS (ESI): m/z 
[M+H]+ Calcd. for:C11H23O2: 187.1698, Found: 187.1692, 
[M+Na]+ Calcd. for C11H22NaO2: 209.1518, Found: 209.1511. 
rac-syn-Non-1-ene-3,5-diol ((±)-13) and rac-anti-Non-1-
ene-3,5-diol ((±)-17). Procedure A: To a suspension of NaBH4 
(0.42 g, 11.20 mmol, 2.5 equiv) in benzene (27 mL) was added 
dropwise solution of hydroxyketone 35 (0.70 g, 4.48 mmol, 1 
equiv) in benzene (27 mL) at room temperature. After stirring 
for 21h a solution of HCl (2 M, 80 mL) and EtOAc (80 mL) 
were added. Organic phase was separated, and aqueous phase 
was extracted with EtOAc (3x80 mL). Combined organic 
phases were dried over Na2SO4 and concentrated in vacuo. The 
crude product was purified by MPLC (isocratic 
hexanes/EtOAc: 80/20) providing diols (±)-13 (0.18 g, 25%, 
pale yellow oil) and (±)-17 (0.26 g, 37%, pale yellow oil). All 
physical and spectral data were in good agreement with the 
literature.18 Procedure B: To a suspension of NaBH(OAc)3 (4.75 
g, 22.40 mmol, 5 equiv) in benzene (27 mL) was added 
dropwise solution of hydroxyketone 35 (0.70 g, 4.48 mmol, 1 
equiv) in benzene (27 mL) at room temperature. After 18h of 
stirring a solution of HCl (2 M, 23 mL) and EtOAc (80 mL) 
were added. Organic phase was separated, and aqueous phase 
was extracted with EtOAc (3x80 mL). Combined organic 
phases were dried over Na2SO4 and concentrated in vacuo. The 
crude product was purified by MPLC (isocratic 
hexanes/EtOAc: 80/20) providing diols (±)-13 (0.13 g, 18%, 
pale yellow oil) and (±)-17 (0.38 g, 54%, pale yellow oil). All 
physical and spectral data were in good agreement with the 
literature.18 (±)-13: Rf = 0.15 (hexanes/EtOAc, 4:1); IR (ATR) 
νmax 3346, 2931, 1711, 1422, 990 cm-1; 1H NMR (300 MHz, 
CDCl3) δH 5.89 (ddd, J = 17.2, 10.4, 5.9 Hz, 1H, H-2), 5.26 (dt, 
J = 17.2, 1.4 Hz, 1H, H-1a), 5.10 (dt, J = 10.4, 1.4 Hz, 1H, H-
1b), 4.43-4.33 (m, 1H, H-3), 3.95-3.83 (m, 1H, H-5), 2.60 (s, 
2H, OH), 1.75-1.20 (m, 8H, H-4, H-6, H-7 and H-8), 0.91 (t, J 
= 7.0, 3H, CH3) ppm; 13C NMR{1H} (75 MHz, CDCl3) δC 
140.9, 114.6, 74.0, 72.7, 43.2, 38.0, 27.7, 22.8, 14.2 ppm; 
HRMS (ESI): m/z [M+Na]+ Calcd. for C9H18NaO2: 181.1205, 
Found: 181.1200; (±)-17: Rf = 0.15 (hexanes/EtOAc, 4:1); IR 
(ATR) νmax 3347, 2931, 1421, 1042, 921 cm-1; 1H NMR (300 
MHz, CDCl3) δH 5.94 (ddd, J = 17.2, 10.5, 5.4 Hz, 1H, H-2), 
5.30 (dt, J = 17.2, 1.5 Hz, 1H, H-1a), 5.15 (dt, J = 10.5, 1.5 Hz, 
1H, H-1b), 4.54-4.43 (m, 1H, H-3), 3.99-3.89 (m, 1H, H-5), 2.36 
(s, 2H, OH), 1.80-1.62 (m, 2H, H-4) 1.61-1.17 (m, 6H, H-6, H-
7 and H-8), 5.15 (t, J = 7.0 Hz, 3H, CH3) ppm; 13C NMR{1H} 
(75 MHz, CDCl3) δC 140.9, 114.5, 70.9, 69.5, 42.3, 37.5, 28.0, 
22.8, 14.2 ppm; HRMS (ESI): m/z [M+Na]+ Calcd. for 
C9H18NaO2: 181.1205, Found: 181.1200. 
3-Hydroxy-1-phenylpent-4-en-1-one (36). To a solution of 
iPr2NH (7.3 mL, 66.58 mmol, 1.6 equiv) in anhydrous THF (83 
mL) was added dropwise solution of nBuLi (39 mL, 1.6 M in 
hexanes, 62.42 mmol, 1.5 equiv) at -78 °C. The mixture was left 
 
to stir for 30 min and then solution of acetophenone (4.9 mL, 
41.62 mol, 1 equiv) in anhydrous THF (21 mL) was added 
dropwise at the same temperature. After stirring over period of 
1 h at -78 °C, solution of acrolein (3.3 mL, 49.94 mmol, 
1.2 equiv) in anhydrous THF (17 mL) was added dropwise and 
resulting mixture was stirred for 1 h. The reaction was quenched 
with saturated solution of NH4Cl (50 mL) and diluted with Et2O 
(50 mL). Subsequently, organic phase was separated, and 
aqueous phase was extracted with Et2O (3x100 mL). The 
combined organic extracts were dried over Na2SO4, filtered and 
concentrated in vacuo. Purification of crude product by MPLC 
(isocratic hexanes/EtOAc: 85/15) provided hydroxyketone 36 
(3.54 g, 48%, pale yellow oil). Rf = 0.15 (hexanes/EtOAc, 17:3); 
IR (ATR) νmax 3433, 1675, 1211, 753, 687 cm-1; 1H NMR (300 
MHz, CDCl3) δH 7.97 (ddd, J = 7.1, 3.1, 1.7 Hz, 2H, HAr), 7.64-
7.56 (m, 1H, HAr), 7.52-7.44 (m, 2H, HAr), 5.98 (ddd, J = 17.2, 
10.5, 5.6 Hz, 1H, H-4), 5.37 (dt, J = 17.2, 1.5 Hz, 1H, H-5a), 
5.19 (dt, J = 10.5, 1.5 Hz, 1H, H-5b), 4.47 (dddt, J = 7.8, 5.6, 
3.8, 1.5 Hz, 1H, H-3), 3.24 (dd, J = 16.5, 3.8 Hz, 1H, H-2a), 3.17 
(dd, J = 16.5, 7.8 Hz, 1H, H-2b) ppm; 13C NMR{1H} (75 MHz, 
CDCl3) δC 200.2, 139.2, 136.8, 133.7, 128.8, 128.3, 115.3, 68.9, 
45.0 ppm; HRMS (ESI): m/z [M+H]+ Calcd. for:C11H13O2: 
177.0916, Found: 177.0910, [M+Na]+ Calcd. for C11H12NaO2: 
199.0735, Found: 199.0729, [M+K]+ Calcd. for C11H12KO2: 
215.0474, Found: 215.0468. 
1-Phenylpent-4-ene-1,3-diol ((±)-19). To a solution of 
hydroxyketone 36 (1.04 g, 5.87 mmol, 1 equiv) in anhydrous 
EtOH (29 mL) was added in small portions NaBH4 (0.66 g, 
17.33 mmol, 2.95 equiv) at 0 °C and the mixture was left to stir 
at this temperature for 1 h. Subsequently, solution of HCl (2 M, 
45 mL) was added, resulting mixture was stirred 5 min at room 
temperature and then EtOH was removed in vacuo. The residue 
was dissolved in EtOAc (50 mL), organic phase was separated, 
and the aqueous phase was extracted with EtOAc (2x50 mL). 
Combined organic phases were dried over Na2SO4, filtered and 
concentrated in vacuo. Purification of crude product by MPLC 
(hexanes/EtOAc: 100/0 to 70/30 then isocratic hexanes/EtOAc: 
70/30) provided inseparable mixture of diols (±)-19 (0.85 g, 
83%, colorless oil, syn/anti = 53/47 based on 1H NMR). All 
physical and spectral data were in good agreement with the 
literature.45 (±)-syn-19: Rf = 0.20 (hexanes/EtOAc, 7:3); 1H 
NMR (300 MHz, CDCl3) δH 7.40-7.25 (m, 5H, HAr), 5.93-5.82 
(m, 1H, H-4), 5.28 (dt, J = 17.2, 1.4 Hz, 1H, H-5a), 5.12 (dt, J = 
10.4, 1.4 Hz, 1H, H-5b), 4.97 (dd, J = 9.6, 3.3 Hz, 1H, H-1), 
4.44-4.37 (m, 1H, H-3), 2.63 (s, 2H, OH), 2.04-1.93 (m, 1H, H-
2a), 1.87-1.80 (m, 1H, H-2b) ppm; 13C NMR{1H} (75 MHz, 
CDCl3) δC 144.4, 140.5, 128.6, 127.6, 125.7, 114.8, 73.5, 70.6, 
44.4 ppm; (±)-anti-19: Rf = 0.20 (hexanes/EtOAc, 7:3); 1H 
NMR (300 MHz, CDCl3) δH 7.40-7.25 (m, 5H, HAr), 6.02-5.90 
(m, 1H, H-4), 5.30 (dt, J = 17.2, 1.5 Hz, 1H, H-5a), 5.17 (dt, J = 
10.5, 1.5 Hz, 1H, H-5b), 5.04 (dd, J = 8.7, 3.2 Hz, 1H, H-1), 
4.52-4.44 (m, 1H, H-3), 2.63 (s, 2H, OH), 2.11-2.03 (m, 1H, H-
2a), 1.94-1.87 (m, 1H, H-2b) ppm; 13C NMR{1H} (75 MHz, 
CDCl3) δC 144.4, 140.5, 128.6, 127.8, 125.8, 114.8, 74.9, 71.7, 
45.4 ppm; (±)-19: IR (ATR) νmax 3381, 1393, 1056, 756, 698 
cm-1; HRMS (ESI): m/z [M+Na]+ Calcd. for C11H14NaO2: 
201.0892, Found: 201.0886, [M+K]+ Calcd. for C11H14KO2: 
217.0631, Found: 217.0624. 
Hept-6-en-2-ol ((±)-23). To a suspension of Mg (12.6 g, 
518.50 mmol, 1.4 equiv) in anhydrous THF (296 mL) were 
added dropwise 1,2-dibromoethane (6.96 g, 37.04 mmol, 0.1 
equiv) and then 4-bromobut-1-ene (37.6 mL, 370.36 mmol, 1 
equiv). The resulting mixture was left to stir for 2 h and then it 
was added dropwise at -78 °C to the suspension of propylene 
oxide (20.7 mL, 296.29 mmol, 0.8 equiv) and CuI (5.64 g, 29.6 
mmol, 0.08 equiv) in anhydrous THF (158 mL). After stirring 
over a period of 1.5 h at -78 °C, the reaction mixture was left to 
warm to room temperature and stirred at this temperature for 1 
h. Subsequently, the reaction was quenched with NH4Cl (400 
mL), the organic phase was separated, and the aqueous phase 
was extracted with Et2O (3x400 mL). Combined organic phases 
were dried over Na2SO4, filtered and concentrated in vacuo. 
Distillation of a crude product (17-20 mbar, 65-70 °C) afforded 
alcohol (±)-23 (24.33 g, 72%, colorless oil). All physical and 
spectral data were in good agreement with the literature.46 Rf = 
0.20 (hexanes/EtOAc, 4:1); IR (ATR) νmax 3332, 2930, 1120, 
908, 639 cm-1; 1H NMR (300 MHz, CDCl3) δH 5.80 (ddt, J = 
16.9, 10.2, 6.7 Hz, 1H, H-6), 5.06-4.91 (m, 2H, H-7), 3.86-3.73 
(m, 1H, H-2), 2.16-1.98 (m, 2H, H-5), 1.65-1.34 (m, 4H, H-3 
and H-4), 1.18 (d, J = 6.2 Hz, 3H, CH3) ppm; 13C NMR{1H} 
(75 MHz, CDCl3) δC 138.8, 114.7, 68.2, 38.9, 33.8, 25.2, 23.7 
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